Index

All guidance by type

NICE clinical guidelines

Ref Title Date issued
CG2 Infection control: prevention of healthcare-associated infection in primary and community care June 2003
CG3 Preoperative tests June 2003
CG5 Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care July 2003
CG7 Pressure ulcer prevention: pressure ulcer risk assessment and prevention, including the use of pressure-relieving devices (beds, mattresses and overlays) for the prevention of pressure ulcers in primary and secondary care October 2003
CG8 Multiple sclerosis November 2003
CG9 Eating disorders January 2004
CG10 Type 2 diabetes foot problems January 2004
CG11 Fertility: assessment and treatment for people with fertility problems February 2004
CG12 Chronic obstructive pulmonary disease: Management of chronic obstructive pulmonary disease in adults in primary and secondary care February 2004
CG13 Caesarean section April 2004
CG15 Type 1 diabetes July 2014
CG16 Self-harm July 2004
CG17 Dyspepsia June 2005
CG19 Dental recall October 2004
CG20 The epilepsies: The diagnosis and management of the epilepsies in adults and children in primary and secondary care October 2004
CG21 Falls: the assessment and prevention of falls in older people November 2004
CG22 Anxiety (amended) December 2004
CG24 Lung cancer: diagnosis and treatment February 2005
CG25 Violence February 2005
CG26 Post-traumatic stress disorder (PTSD) March 2005
CG27 Referral guidelines for suspected cancer April 2011
CG28 Depression in children and young people September 2005
CG29 Pressure ulcers: the management of pressure ulcers in primary and secondary care September 2005
CG30 Long-acting reversible contraception April 2013
CG31 Obsessive-compulsive disorder November 2005
CG32 Nutrition support in adults February 2006
CG33 Tuberculosis: Clinical diagnosis and management of tuberculosis, and measures for its prevention and control March 2006
CG34 Hypertension: management of hypertension in adults in primary care June 2006
CG35 Parkinson's disease June 2006
CG36 Atrial fibrillation: The management of atrial fibrillation June 2006
CG37 Postnatal care July 2006
CG38 Bipolar disorder July 2006
CG39 Anaemia management in people with chronic kidney disease September 2006
CG40 Urinary incontinence: the management of urinary incontinence in women October 2006
CG41 Familial breast cancer October 2006
CG42 Dementia November 2006
CG43 Obesity May 2014
CG44 Heavy menstrual bleeding January 2007
CG45 Antenatal and postnatal mental health April 2007
CG47 Feverish illness in children: assessment and initial management in children younger than 5 years May 2007
CG48 MI – secondary prevention: Secondary prevention in primary and secondary care for patients following a myocardial infarction May 2007
CG49 Faecal incontinence June 2007
CG50 Acutely ill patients in hospital July 2007
CG51 Drug misuse – psychosocial interventions July 2007
CG52 Drug misuse – opioid detoxification July 2007
CG53 Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) August 2007
CG54 Urinary tract infection in children August 2007
CG55 Intrapartum care September 2007
CG56 Head injury: Triage, assessment, investigation and early management of head injury in infants, children and adults September 2007
CG57 Atopic eczema in children December 2007
CG58 Prostate cancer: diagnosis and treatment February 2008
CG59 Osteoarthritis: the care and management of osteoarthritis in adults February 2008
CG60 Surgical management of otitis media with effusion in children February 2008
CG61 Irritable bowel syndrome in adults February 2008
CG62 Antenatal care June 2010
CG63 Diabetes in pregnancy July 2008
CG64 Prophylaxis against infective endocarditis March 2008
CG65 Inadvertent perioperative hypothermia April 2008
CG67 Lipid modification: Cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease May 2008
CG68 Stroke July 2008
CG69 Respiratory tract infections – antibiotic prescribing July 2008
CG70 Induction of labour July 2008
CG71 Identification and management of familial hypercholesterolaemia August 2008
CG72 Attention deficit hyperactivity disorder March 2013
CG73 Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care September 2008
CG74 Surgical site infection October 2008
CG75 Metastatic spinal cord compression November 2008
CG76 Medicines adherence January 2009
CG77 Antisocial personality disorder September 2013
CG78 Borderline personality disorder January 2009
CG79 Rheumatoid arthritis August 2013
CG80 Early and locally advanced breast cancer July 2014
CG81 Advanced breast cancer (update) July 2014
CG82 Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary March 2009
CG83 Rehabilitation after critical illness March 2009
CG84 Diarrhoea and vomiting in children April 2009
CG85 Glaucoma April 2009
CG86 Coeliac disease May 2009
CG87 Type 2 diabetes July 2014
CG88 Low back pain May 2009
CG89 When to suspect child maltreatment March 2013
CG90 Depression in adults October 2009
CG91 Depression in adults with a chronic physical health problem October 2009
CG92 Venous thromboembolism: reducing the risk January 2010
CG93 Donor milk banks: the operation of donor milk bank services February 2010
CG94 Unstable angina and NSTEMI November 2013
CG95 Chest pain of recent onset March 2010
CG96 Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings March 2010
CG97 Lower urinary tract symptoms May 2010
CG98 Neonatal jaundice May 2010
CG99 Constipation in children and young people May 2010
CG100 Alcohol-use disorders: Diagnosis and clinical management of alcohol-related physical complications June 2010
CG101 Chronic obstructive pulmonary disease June 2010
CG102 Bacterial meningitis and meningococcal septicaemia September 2010
CG103 Delirium July 2010
CG104 Metastatic malignant disease of unknown primary origin July 2010
CG105 Motor neurone disease July 2010
CG106 Barrett's oesophagus August 2010
CG107 Hypertension in pregnancy January 2011
CG108 Chronic heart failure August 2010
CG109 Transient loss of consciousness ('blackouts') management in adults and young people August 2010
CG110 Pregnancy and complex social factors September 2010
CG111 Nocturnal enuresis October 2010
CG112 Sedation in children and young people December 2010
CG113 Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults January 2011
CG114 Anaemia management in people with chronic kidney disease February 2011
CG115 Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence February 2011
CG116 Food allergy in children and young people February 2011
CG117 Tuberculosis March 2011
CG118 Colonoscopic surveillance for prevention of colorectal cancer in people with ulcerative colitis, Crohn's disease or adenomas March 2011
CG119 Diabetic foot problems March 2011
CG120 Psychosis with coexisting substance misuse March 2011
CG121 Lung cancer April 2011
CG122 Ovarian cancer April 2011
CG123 Common mental health disorders May 2011
CG124 Hip fracture March 2014
CG125 Peritoneal dialysis July 2011
CG126 Management of stable angina December 2012
CG127 Hypertension August 2011
CG128 Autism diagnosis in children and young people September 2011
CG129 Multiple pregnancy September 2011
CG130 Hyperglycaemia in acute coronary syndromes October 2011
CG131 Colorectal cancer November 2011
CG132 Caesarean section August 2012
CG133 Self-harm: longer-term management November 2011
CG134 Anaphylaxis: assessment to confirm an anaphylactic episode and the decision to refer after emergency treatment for a suspected anaphylactic episode December 2011
CG135 Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation December 2011
CG136 Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services December 2011
CG137 The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care December 2013
CG138 Patient experience in adult NHS services: improving the experience of care for people using adult NHS services February 2012
CG139 Infection March 2012
CG140 Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults May 2012
CG141 Acute upper gastrointestinal bleeding: management June 2012
CG142 Autism: recognition, referral, diagnosis and management of adults on the autism spectrum June 2012
CG143 Sickle cell acute painful episode: management of an acute painful sickle cell episode in hospital June 2012
CG144 Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012
CG145 Spasticity in children and young people with non-progressive brain disorders July 2012
CG146 Osteoporosis: assessing the risk of fragility fracture August 2012
CG147 Lower limb peripheral arterial disease: diagnosis and management August 2012
CG148 Urinary incontinence in neurological disease August 2012
CG149 Antibiotics for early-onset neonatal infection August 2012
CG150 Headaches September 2012
CG151 Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients September 2012
CG152 Crohn's disease October 2012
CG153 Psoriasis October 2012
CG154 Ectopic pregnancy and miscarriage December 2012
CG155 Psychosis and schizophrenia in children and young people January 2013
CG156 Fertility February 2013
CG157 Hyperphosphataemia in chronic kidney disease March 2013
CG158 Antisocial behaviour and conduct disorders in children and young people: recognition, intervention and management March 2013
CG159 Social anxiety disorder: recognition, assessment and treatment May 2013
CG160 Feverish illness in children May 2013
CG161 Falls: assessment and prevention of falls in older people June 2013
CG162 Stroke rehabilitation June 2013
CG163 Idiopathic pulmonary fibrosis June 2013
CG164 Familial breast cancer June 2013
CG165 Hepatitis B (chronic) June 2013
CG166 Ulcerative colitis June 2013
CG167 Myocardial infarction with ST-segment elevation July 2013
CG168 Varicose veins in the legs July 2013
CG169 Acute kidney injury August 2013
CG170 Autism August 2013
CG171 Urinary incontinence September 2013
CG172 MI – secondary prevention November 2013
CG173 Neuropathic pain – pharmacological management November 2013
CG174 Intravenous fluid therapy in adults in hospital December 2013
CG175 Prostate cancer: diagnosis and treatment January 2014
CG176 Head injury January 2014
CG177 Osteoarthritis February 2014
CG178 Psychosis and schizophrenia in adults: treatment and management March 2014
CG179 Pressure ulcers: prevention and management of pressure ulcers April 2014
CG180 Atrial fibrillation: the management of atrial fibrillation June 2014
CG181 Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease July 2014
CG182 Chronic kidney disease July 2014

Commissioning guides

Ref Title Date issued
CMG36 Weight management before, during and after pregnancy March 2011
CMG37 Early identification and management of chronic kidney disease in adults July 2012
CMG38 Services for the identification and treatment of hazardous drinking, harmful drinking and alcohol dependence in children, young people and adults August 2011
CMG39 Services for people with chronic heart failure October 2011
CMG40 Cardiac rehabilitation services November 2013
CMG41 Commissioning stepped care for people with common mental health disorders November 2011
CMG42 Guide for commissioners on end of life care for adults December 2011
CMG43 Services for people with chronic obstructive pulmonary disease October 2011
CMG44 Services for people at risk of developing glaucoma March 2012
CMG45 Services for the prevention of cardiovascular disease May 2012
CMG46 Management of hip fracture in adults November 2012
CMG47 Diagnosis and management of the epilepsies in adults, children and young people February 2013
CMG48 Support for commissioning dementia care April 2013
CMG49 Support for commissioning: anticoagulation therapy May 2013
CMG50 Support for commissioning for self‑harm June 2013
CMG51 Support for commissioning for rheumatoid arthritis June 2013

NICE diagnostics guidance

Ref Title Date issued
DG1 The EOS 2D/3D imaging system October 2011
DG2 Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia December 2011
DG3 New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners January 2012
DG4 Adjunctive colposcopy technologies for examination of the uterine cervix – DySIS and the Niris Imaging System August 2012
DG5 SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver August 2012
DG6 Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M November 2012
DG7 SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of diarrhoea due to bile acid malabsorption in people with diarrhoea-predominant irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection November 2012
DG8 Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer August 2013
DG9 EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer August 2013
DG10 Gene expression profiling and expanded immunohistochemistry tests for guiding adjuvant chemotherapy decisions in early breast cancer management: MammaPrint, Oncotype DX, IHC4 and Mammostrat September 2013
DG11 Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel October 2013
DG12 Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath April 2014

Evidence summary: new medicine

Ref Title Date issued
ESNM1 Clostridium difficile infection: fidaxomicin July 2012
ESNM2 Idiopathic overactive bladder syndrome: botulinum toxin A September 2012
ESNM3 ESNM3: Asthma: fluticasone/formoterol (Flutiform) combination inhaler October 2012
ESNM4 ESNM4: Type 2 diabetes: insulin degludec November 2012
ESNM5 ESNM5: Type 1 diabetes: insulin degludec November 2012
ESNM6 Moderately to severely active ulcerative colitis: adalimumab November 2012
ESNM7 ESNM7: Partial-onset seizures in epilepsy: perampanel as adjunctive treatment December 2012
ESNM8 ESNM8: Chronic obstructive pulmonary disease: aclidinium bromide January 2013
ESNM9 ESNM9: Chronic obstructive pulmonary disease: glycopyrronium bromide January 2013
ESNM10 ESNM10: Type 2 diabetes: lixisenatide January 2013
ESNM11 ESNM11: Acute diarrhoea in adults: racecadotril March 2013
ESNM12 ESNM12: Acute diarrhoea in children: racecadotril as an adjunct to oral rehydration March 2013
ESNM13 ESNM13: Early and metastatic HER2-positive breast cancer: subcutaneous trastuzumab March 2013
ESNM14 ESNM14: Actinic keratosis: ingenol mebutate gel March 2013
ESNM15 ESNM15: Schizophrenia: lurasidone April 2013
ESNM16 ESNM16: Irritable bowel syndrome with constipation in adults: linaclotide April 2013
ESNM17 ESNM17: Partial-onset seizures in epilepsy: zonisamide as monotherapy April 2013
ESNM18 ESNM18: Lower urinary tract symptoms secondary to benign prostatic hyperplasia: tadalafil October 2013
ESNM19 ESNM19: Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate May 2013
ESNM20 ESNM20: Type 2 diabetes: alogliptin May 2013
ESNM21 ESNM21: Chronic obstructive pulmonary disease: fluticasone furoate plus vilanterol June 2013
ESNM22 ESNM22: Asthma: beclometasone/formoterol (Fostair) for maintenance and reliever treatment June 2013
ESNM23 Gouty arthritis: canakinumab July 2013
ESNM24 ESNM24: Type 1 diabetes: insulin degludec September 2013
ESNM25 ESNM25: Type 2 diabetes: insulin degludec September 2013
ESNM26 ESNM26:Type 2 diabetes: lixisenatide September 2013
ESNM27 Secondary prevention in acute coronary syndrome: rivaroxaban October 2013
ESNM28 Combined oral contraception: nomegestrol/estradiol (Zoely) December 2013
ESNM29 ESNM29: Alcohol dependence: nalmefene December 2013
ESNM30 ESNM30: Prostate cancer: triptorelin (Decapeptyl SR) January 2014
ESNM31 ESNM31: Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA‑SC) January 2014
ESNM32 ESNM32: Relapsed and refractory multiple myeloma: pomalidomide February 2014
ESNM33 Chronic obstructive pulmonary disease: indacaterol/glycopyrronium (Ultibro Breezhaler) March 2014
ESNM34 ESNM34: Asthma: fluticasone furoate/vilanterol (Relvar Ellipta) combination inhaler March 2014
ESNM35 ESNM35: Type 2 diabetes: empagliflozin March 2014
ESNM36 ESNM36: Systemic juvenile idiopathic arthritis: canakinumab March 2014
ESNM37 ESNM37: Partial seizures in children and young people with epilepsy: zonisamide as adjunctive therapy March 2014
ESNM38 ESNM38: Induction of labour: misoprostol vaginal delivery system March 2014
ESNM39 ESNM39: Schizophrenia: aripiprazole prolonged-release suspension for injection March 2014
ESNM40 ESNM40: Premature ejaculation: dapoxetine May 2014
ESNM41 ESNM41: Long-acting reversible contraception: levonorgestrel 13.5 mg intrauterine delivery system June 2014
ESNM42 Psoriatic arthritis in adults: certolizumab pegol June 2014
ESNM43 Facial erythema of rosacea: brimonidine tartrate gel July 2014
ESNM44 Hospital-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus: telavancin July 2014

Evidence summary: unlicensed or off-label medicine

Ref Title Date issued
ESUOM1 ESUOM1: Significant haemorrhage following trauma: tranexamic acid October 2012
ESUOM2 ESUOM2: Sleep disorders in children and young people with attention deficit hyperactivity disorder: melatonin January 2013
ESUOM3 ESUOM3: Chronic anal fissure: 2% topical diltiazem hydrochloride January 2013
ESUOM4 ESUOM4: Preventing recurrent hypomagnesaemia: oral magnesium glycerophosphate January 2013
ESUOM5 ESUOM5: Postural hypotension in adults: midodrine February 2013
ESUOM6 ESUOM6: Polycystic ovary syndrome: metformin in women not planning pregnancy February 2013
ESUOM7 ESUOM7: Chronic anal fissure: 0.2% topical glyceryl trinitrate ointment March 2013
ESUOM8 ESUOM8: Attention deficit hyperactivity disorder in children and young people: clonidine April 2013
ESUOM9 ESUOM9: Fatigue in multiple sclerosis: modafinil April 2013
ESUOM10 ESUOM10: Nocturia and nocturnal polyuria in men with lower urinary tract symptoms: oral desmopressin April 2013
ESUOM11 ESUOM11: Induction of labour in late intrauterine fetal death: vaginal misoprostol (after oral mifepristone) April 2013
ESUOM12 ESUOM12: Generalised anxiety disorder: quetiapine May 2013
ESUOM13 ESUOM13: Gastroparesis in adults: oral erythromycin June 2013
ESUOM14 ESUOM14: Chronic anal fissure: botulinum toxin type A injection June 2013
ESUOM15 ESUOM15: Hypersalivation: oral glycopyrronium bromide July 2013
ESUOM16 ESUOM16: Hyperhidrosis: oral glycopyrronium bromide July 2013
ESUOM17 Multidrug resistant urinary tract infections: fosfomycin trometamol July 2013
ESUOM18 ESUOM18: Promoting tolerance of enteral feeds in children and young people: domperidone July 2013
ESUOM19 ESUOM19: Schizophrenia: omega-3 fatty acid medicines September 2013
ESUOM20 Postural hypotension in adults: fludrocortisone October 2013
ESUOM21 ESUOM21: Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatment October 2013
ESUOM22 ESUOM22: Bile acid malabsorption: colesevelam October 2013
ESUOM23 ESUOM23: Transient ischaemic attack: clopidogrel December 2013
ESUOM24 Critical limb ischaemia in peripheral vascular disease: intravenous iloprost December 2013
ESUOM25 ESUOM25: Non-cystic fibrosis bronchiectasis: colistimethate sodium January 2014
ESUOM26 ESUOM26: Interstitial cystitis: dimethyl sulfoxide bladder instillation February 2014
ESUOM27 ESUOM27: Chronic pain: oral ketamine June 2014
ESUOM28 ESUOM28: Rapid tranquillisation in mental health settings: promethazine hydrochloride March 2014
ESUOM29 ESUOM29: Difficult-to-treat scabies: oral ivermectin March 2014
ESUOM30 ESUOM30: Pouchitis: rifaximin March 2014
ESUOM31 ESUOM31: Chronic urticaria: off-label doses of cetirizine July 2014

Good practice guidance

Ref Title Date issued
GPG1 Developing and updating local formularies December 2012
GPG2 Patient Group Directions August 2013

Health technologies adoption programme

Ref Title Date issued
HTAP2 Diagnostic adoption support for measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath (DG12) April 2014
HTAP3 Medical technology adoption support for Inditherm patient warming mattress for the prevention of inadvertent hypothermia (MTG7) March 2014

Information for the public

Ref Title Date issued
IFP8 Multiple sclerosis November 2003
IFP15 Type 1 diabetes in adults July 2014
IFP17 Indigestion (dyspepsia) in adults August 2004
IFP19 When should my next dental check-up be? October 2004
IFP27 Referral guidelines for suspected cancer June 2005
IFP29 Pressure ulcers – prevention and treatment September 2005
IFP30 Long-acting reversible contraception April 2013
IFP32 Nutrition support in adults February 2006
IFP35 Parkinson's disease June 2006
IFP36 Atrial fibrillation June 2006
IFP37 Care of women and their babies in the first 6–8 weeks after birth July 2008
IFP38 Bipolar disorder July 2006
IFP42 Dementia: supporting people with dementia and their carers November 2006
IFP44 Treatment and care for women with heavy periods January 2007
IFP45 Mental health problems during pregnancy and after giving birth February 2007
IFP49 Faecal incontinence (bowel control problems) June 2007
IFP50 Monitoring patients in hospital and caring for them if their health becomes worse July 2007
IFP53 Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy) August 2007
IFP54 Urinary tract infection (UTI) in children August 2007
IFP55 Care of women and their babies during labour September 2007
IFP57 Atopic eczema in children up to 12 years December 2007
IFP58 Prostate cancer February 2008
IFP59 Osteoarthritis February 2008
IFP60 Surgical management of glue ear in children February 2008
IFP61 Irritable bowel syndrome February 2008
IFP62 Routine antenatal care for healthy pregnant women March 2008
IFP63 Diabetes in pregnancy March 2008
IFP64 Preventing infective endocarditis March 2008
IFP65 Keeping patients warm before, during and after an operation April 2008
IFP67 Lowering cholesterol to reduce the risk of heart disease, stroke and peripheral arterial disease May 2008
IFP68 Early assessment and treatment of people who have had a stroke or transient ischaemic attack (TIA) July 2008
IFP69 Use of antibiotics for respiratory tract infections in adults and children July 2008
IFP70 Induction of labour July 2008
IFP71 Inherited high cholesterol in the family (familial hypercholesterolaemia) August 2008
IFP72 Attention deficit hyperactivity disorder September 2008
IFP73 Identifying and treating long-term kidney problems (chronic kidney disease) September 2008
IFP74 Preventing and treating surgical site infections October 2008
IFP75 Metastatic spinal cord compression November 2008
IFP76 You and your prescribed medicines: enabling and supporting patients to make informed decisions January 2009
IFP77 Antisocial personality disorder March 2013
IFP78 Borderline personality disorder January 2009
IFP79 Rheumatoid arthritis in adults February 2009
IFP80 Early and locally advanced breast cancer July 2014
IFP81 Advanced breast cancer July 2014
IFP82 Schizophrenia March 2009
IFP83 Rehabilitation after critical illness March 2009
IFP84 Diarrhoea and vomiting in children April 2009
IFP85 Diagnosing and treating glaucoma and raised eye pressure April 2009
IFP86 Coeliac disease: recognition and assessment of coeliac disease May 2009
IFP87 Type 2 diabetes May 2009
IFP88 Early management of persistent non-specific low back pain May 2009
IFP89 When to suspect child maltreatment July 2009
IFP90 Treating depression in adults October 2009
IFP91 Treating depression in adults with a long-term physical health problem October 2009
IFP93 Collecting and storing donor breast milk in milk banks February 2010
IFP94 Unstable angina and NSTEMI November 2013
IFP95 Chest pain March 2010
IFP97 Lower urinary tract symptoms in men May 2010
IFP98 Jaundice in newborn babies May 2010
IFP99 Constipation in children and young people May 2010
IFP100 Physical health problems caused by drinking alcohol June 2010
IFP101 Chronic obstructive pulmonary disease June 2010
IFP102 Bacterial meningitis and meningococcal septicaemia in children and young people June 2010
IFP103 Delirium July 2010
IFP104 Cancer of unknown primary July 2010
IFP105 Non-invasive ventilation for people with motor neurone disease July 2010
IFP106 Ablative therapies for Barrett's oesophagus July 2010
IFP107 High blood pressure in pregnancy August 2010
IFP108 Chronic heart failure August 2010
IFP109 Management of a blackout (transient loss of consciousness) in adults and young people August 2010
IFP110 Helping pregnant women make the best use of antenatal care services September 2010
IFP111 Bedwetting in children and young people October 2010
IFP112 Sedation for children and young people December 2010
IFP113 Treating generalised anxiety disorder and panic disorder in adults January 2011
IFP114 Treating anaemia in people with chronic kidney disease February 2011
IFP115 Treating harmful drinking and alcohol dependence February 2011
IFP116 Testing for food allergy in children and young people February 2011
IFP117 Tuberculosis March 2011
IFP118 Surveillance of the large bowel: preventing cancer in people at risk March 2011
IFP119 Hospital-based treatment of diabetic foot problems March 2011
IFP120 Treatment and support for people with psychosis who use drugs and/or alcohol March 2011
IFP121 The diagnosis and treatment of lung cancer April 2011
IFP122 Recognition and initial treatment of ovarian cancer April 2011
IFP123 Getting help and support for common mental health problems May 2011
IFP124 Hip fracture in adults June 2011
IFP125 Peritoneal dialysis for people with kidney failure July 2011
IFP126 Stable angina July 2011
IFP127 High blood pressure August 2011
IFP128 Diagnosing autism in children and young people September 2011
IFP129 Antenatal care for women who are pregnant with twins or triplets September 2011
IFP130 High blood glucose after an acute coronary syndrome October 2011
IFP131 Colorectal cancer November 2011
IFP132 Caesarean section November 2011
IFP133 Longer-term care and treatment of self-harm November 2011
IFP134 Anaphylaxis December 2011
IFP135 Improving identification and consent rates for organ donation December 2011
IFP136 Improving your experience of mental health services in the NHS December 2011
IFP137 The diagnosis and management of epilepsy in children, young people and adults January 2012
IFP138 Experiencing good NHS care: what you can expect February 2012
IFP139 Preventing infections in people having treatment or care at home or in the community March 2012
IFP140 Managing pain with strong opioids in people with advanced, progressive disease May 2012
IFP141 Acute upper gastrointestinal bleeding June 2012
IFP142 Diagnosing, supporting and caring for adults with autism June 2012
IFP143 Treating acute painful sickle cell episodes in hospital June 2012
IFP145 Spasticity in children and young people July 2012
IFP146 Assessing the risk of osteoporosis-related fractures August 2012
IFP147 Lower limb peripheral arterial disease August 2012
IFP148 Managing urinary incontinence in people with a neurological condition August 2012
IFP149 The use of antibiotics to prevent and treat early-onset bacterial infection in newborn babies August 2012
IFP150 Headaches September 2012
IFP151 Neutropenic sepsis in people having anticancer treatment September 2012
IFP152 Crohn's disease October 2012
IFP153 Psoriasis October 2012
IFP154 Ectopic pregnancy and miscarriage in early pregnancy December 2012
IFP155 Psychosis and schizophrenia in children and young people January 2013
IFP156 Assessment and treatment for people with fertility problems February 2013
IFP157 Hyperphosphataemia in chronic kidney disease March 2013
IFP158 Antisocial behaviour and conduct disorders in children and young people March 2013
IFP159 Social anxiety disorder May 2013
IFP160 Fever in children younger than 5 years May 2013
IFP161 Preventing falls in older people June 2013
IFP162 Rehabilitation after a stroke June 2013
IFP163 Idiopathic pulmonary fibrosis June 2013
IFP164 Familial breast cancer (breast cancer in the family) June 2013
IFP165 Chronic hepatitis B June 2013
IFP166 Ulcerative colitis June 2013
IFP167 Emergency assessment and treatment for a heart attack July 2013
IFP168 Varicose veins in the legs July 2013
IFP169 Acute kidney injury August 2013
IFP170 Managing autism in children and young people August 2013
IFP171 Managing urinary incontinence in women September 2013
IFP172 Preventing another heart attack November 2013
IFP173 Drug treatments for neuropathic pain November 2013
IFP174 Intravenous fluid therapy for adults in hospital December 2013
IFP175 Prostate cancer January 2014
IFP176 The early management of head injuries January 2014
IFP177 Osteoarthritis February 2014
IFP178 Psychosis and schizophrenia in adults February 2014
IFP179 Pressure ulcer prevention, treatment and care April 2014
IFP180 Atrial fibrillation June 2014
IFP181 Lowering cholesterol to reduce the risk of coronary heart disease and stroke July 2014
IFP182 Identifying and treating chronic kidney disease (CKD) July 2014

Information for the public: interventional procedures

Ref Title Date issued
IFPIP464 Endoscopic radiofrequency ablation for treating bile or pancreatic duct obstructions caused by cancer September 2013
IFPIP465 Endobronchial valves for lung volume reduction in emphysema September 2013
IFPIP466 Treating keratoconus and keratectasia by corneal collagen cross‑linking using riboflavin eye drops and UV light September 2013
IFPIP467 Vacuum (negative pressure) therapy for open abdominal wounds November 2013
IFPIP468 Phrenic nerve transfer in brachial plexus injury November 2013
IFPIP469 Microwave ablation for lung cancer November 2013
IFPIP470 Ultra-radical (extensive) surgery for advanced ovarian cancer November 2013
IFPIP471 Inserting an artificial sleeve into the bowel for managing obesity November 2013
IFPIP472 Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events December 2013
IFPIP473 Uterine artery embolisation for treating adenomyosis December 2013
IFPIP474 Stabilising the kneecap using arthroscopic trochleoplasty January 2014
IFPIP475 Relieving lower urinary tract symptoms from prostate enlargement by inserting implants into the prostate January 2014
IFPIP476 Radiofrequency ablation of the soft palate for snoring January 2014
IFPIP477 Treating and preventing migraine by magnetic stimulation of the brain January 2014
IFPIP478 Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma February 2014
IFPIP479 Subcutaneous battery-powered catheter drainage system for ascites February 2014
IFPIP480 Endoscopic thoracic sympathectomy for blushing February 2014
IFPIP481 Optical coherence imaging to guide procedures on the arteries supplying the heart February 2014
IFPIP482 Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults March 2014
IFPIP483 Inserting a magnetic bead band for faecal incontinence March 2014
IFPIP484 Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy March 2014
IFPIP485 Faecal transplant for recurring Clostridium difficile infection March 2014
IFPIP486 Hysteroscopic morcellation of uterine fibroids April 2014
IFPIP487 Endoscopic thoracic sympathectomy for severe sweating from the palms and underarms May 2014
IFPIP488 Treating primary or metastatic liver cancer with chemosaturation targeted at the liver May 2014
IFPIP489 Gastroelectrical stimulation for gastroparesis May 2014
IFPIP490 Transcutaneous neuromuscular electrical stimulation for dysphagia May 2014
IFPIP491 Platelet-rich plasma injections for osteoarthritis of the knee May 2014
IFPIP492 Bioresorbable stents for coronary artery disease May 2014
IFPIP493 Keyhole surgery using radiofrequency chondroplasty to remove small defects in knee cartilage June 2014
IFPIP494 Keyhole saphenous vein harvesting for coronary artery bypass grafting June 2014
IFPIP495 Radiofrequency tissue reduction for turbinate hypertrophy June 2014
IFPIP496 Treating Barrett's oesophagus with low‑grade or no dysplasia with endoscopic radiofrequency energy July 2014
IFPIP497 Treating squamous dysplasia of the oesophagus with endoscopic radiofrequency energy July 2014
IFPIP498 Powered microdebrider turbinoplasty for inferior turbinate hypertrophy July 2014

Information for the public: quality standards

Ref Title Date issued
IFPQS23 Information for people who use NHS services for drug use disorders April 2014
IFPQS49 NICE quality standard for surgical site infection October 2013
IFPQS50 NICE quality standard for mental wellbeing of older people in care homes December 2013
IFPQS51 NICE quality standard for autism January 2014
IFPQS52 NICE quality standard for peripheral arterial disease January 2014
IFPQS53 NICE quality standard for anxiety disorder February 2014
IFPQS54 NICE quality standard for faecal incontinence February 2014
IFPQS55 NICE quality standard for children and young people with cancer February 2014
IFPQS56 NICE quality standard for metastatic spinal cord compression February 2014
IFPQS57 NICE quality standard for neonatal jaundice March 2014
IFPQS58 NICE quality standard for sickle cell acute painful episode April 2014
IFPQS59 NICE quality standard for antisocial behaviour and conduct disorders in children and young people April 2014
IFPQS60 NICE quality standard for induction of labour April 2014
IFPQS61 NICE quality standard for infection prevention and control April 2014
IFPQS62 NICE quality standard for constipation in children and young people May 2014

Information for the public: safe staffing

Ref Title Date issued
IFPSG1 Making sure there are enough nursing staff in adult wards in hospitals July 2014

Information for the public: technology appraisals

Ref Title Date issued
IFPTA294 Aflibercept injection for treating wet age-related degeneration July 2013
IFPTA297 Ocriplasmin for vitreomacular traction October 2013
IFPTA298 Ranibizumab for choroidal neovascularisation and pathological myopia November 2013
IFPTA299 Bosutinib for previously treated chronic myeloid leukaemia November 2013
IFPTA300 Peginterferon alfa and ribavirin for chronic hepatitis C in children and young people November 2013
IFPTA301 Fluocinolone acetonide intravitreal implants for chronic diabetic macular oedema November 2013
IFPTA303 Teriflunomide for relapsing–remitting multiple sclerosis January 2013
IFPTA304 Artificial hips and hip resurfacing for end-stage hip arthritis February 2014
IFPTA305 Aflibercept injections for sight problems caused by macular oedema from central retinal vein occlusion February 2014
IFPTA306 Pixantrone for multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma February 2014
IFPTA307 Aflibercept with chemotherapy for previously treated metastatic colorectal cancer March 2014
IFPTA308 Rituximab with glucocorticoids for anti-neutrophil cytoplasmic antibody-associated vasculitis March 2014
IFPTA309 Pemetrexed as maintenance treatment for non-small-cell lung cancer after pemetrexed and cisplatin April 2014
IFPTA310 Afatinib for treating locally advanced or metastatic non-small-cell lung cancer April 2014
IFPTA311 Bortezomib for multiple myeloma before chemotherapy and stem cell transplant April 2014
IFPTA312 Alemtuzumab for treating active relapsing‑remitting multiple sclerosis May 2014
IFPTA313 Ustekinumab for active psoriatic arthritis May 2014
IFPTA314 Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure June 2014
IFPTA315 Canagliflozin taken with other drugs for treating type 2 diabetes June 2014
IFPTA316 Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen July 2014
IFPTA317 Prasugrel with percutaneous coronary intervention for acute coronary syndromes July 2014
IFPTA318 Lubiprostone for chronic idiopathic constipation July 2014
IFPTA319 Ipilimumab for previously untreated advanced melanoma July 2014

Information for the public – Evidence summary: unlicensed or off-label medicine

Ref Title Date issued
IFPUO1 IFPUO1: Tranexamic acid following trauma October 2012
IFPUO2 IFPUO2: Using melatonin to treat sleep disorders in children and young people with ADHD January 2013
IFPUO3 IFPUO3: 2% Topical diltiazem hydrochloride for chronic anal fissure January 2013
IFPUO4 IFPUO4: Oral magnesium glycerophosphate for preventing hypomagnesaemia from recurring January 2013
IFPUO5 IFPUO5: Midodrine for low blood pressure on standing (postural hypotension) February 2013
IFPUO6 IFPUO6: Metformin for treating polycystic ovary syndrome in women who are not trying to get pregnant February 2013
IFPUO7 IFPUO7: 0.2% Topical glyceryl trinitrate ointment for chronic anal fissure March 2013
IFPUO8 Clonidine for treating attention deficit hyperactivity disorder (ADHD) in children and young people April 2013
IFPUO9 Modafinil for fatigue in multiple sclerosis April 2013
IFPUO10 IFPUO10:Desmopressin for men with urinary symptoms at night April 2013
IFPUO11 IFPUO11: Misoprostol for induction of labour after the late death of an unborn baby in the womb April 2013
IFPUO12 IFPUO12: Quetiapine for generalised anxiety disorder May 2013
IFPUO13 IFPUO13: Erythromycin for gastroparesis (delayed stomach emptying) June 2013
IFPUO14 IFPUO14: Botulinum toxin type A injections for chronic anal fissure June 2013
IFPUO15 IFPUO15: Glycopyrronium for increased saliva production or drooling July 2013
IFPUO16 IFPUO16: Glycopyrronium for excessive sweating July 2013
IFPUO17 Fosfomycin for treating urinary tract infections caused by bacteria that are resistant to more than one antibiotic July 2013
IFPUO18 IFPUO18: Using domperidone to improve feeding tolerance in children and young people being tube fed July 2013
IFPUO19 IFPUO19: Omega-3 fatty acid medicines for schizophrenia September 2013
IFPUO20 Fludrocortisone for low blood pressure on standing (postural hypotension) October 2013
IFPUO21 IFPUO21: Bevacizumab with paclitaxel and carboplatin as first-line treatment for advanced ovarian cancer October 2013
IFPUO22 IFPUO22: Colesevelam for problems with absorbing bile acid (bile acid malabsorption) October 2013
IFPUO23 IFPUO23: Clopidogrel for 'mini-stroke' (transient ischaemic attack or TIA) December 2013
IFPUO24 Intravenous iloprost for chronic, severe restriction of blood flow to the limbs (critical limb ischaemia) December 2013
IFPUO25 IFPUO25: Colistimethate for lung infections in people with damaged airways (bronchiectasis) without cystic fibrosis January 2014
IFPUO26 IFPUO26: Dimethyl sulfoxide for interstitial cystitis February 2014
IFPUO27 IFPUO27: Oral ketamine for chronic pain February 2014
IFPUO28 IFPUO28: Promethazine for rapid tranquillisation March 2014
IFPUO29 IFPUO29: Ivermectin for difficult-to-treat scabies March 2014
IFPUO30 IFPUO30: Rifaximin for pouchitis March 2014
IFPUO31 IFPUO31: Chronic urticaria: higher (off-label) doses of cetirizine July 2014

NICE interventional procedure guidance

Ref Title Date issued
IPG2 Radiofrequency ablation of hepatocellular carcinoma July 2003
IPG6 Balloon thermal endometrial ablation August 2003
IPG7 Microwave endometrial ablation August 2003
IPG8 Radiofrequency ablation of varicose veins September 2003
IPG12 Percutaneous vertebroplasty September 2003
IPG14 Transurethral electrovaporisation of the prostate October 2003
IPG17 Holmium laser prostatectomy November 2003
IPG18 Bone-anchored cystourethropexy November 2003
IPG19 Deep brain stimulation for Parkinson's disease November 2003
IPG21 Extracorporeal shockwave lithotripsy for calcific tendonitis (tendinopathy) of the shoulder November 2003
IPG22 Endoscopic stapling of pharyngeal pouch November 2003
IPG23 Laparoscopic laser myomectomy November 2003
IPG25 Laparo-endogastric surgery December 2003
IPG28 Exposed customised titanium implants for orofacial reconstruction December 2003
IPG29 Extracorporeal shockwave therapy for Peyronie's disease December 2003
IPG30 Magnetic resonance (MR) image-guided percutaneous laser ablation of uterine fibroids December 2003
IPG31 Endoscopic laser foraminoplasty December 2003
IPG031 Endoscopic laser foraminoplasty December 2003
IPG32 Endoscopic transsphenoidal pituitary adenoma resection December 2003
IPG33 Percutaneous pancreatic necrosectomy December 2003
IPG34 Circular stapled haemorrhoidectomy December 2003
IPG35 Off-pump coronary artery bypass June 2007
IPG36 Radiofrequency volumetric tissue reduction for turbinate hypertrophy January 2004
IPG37 Transilluminated powered phlebectomy for varicose veins January 2004
IPG38 Extracorporeal membrane oxygenation (ECMO) in postneonatal children January 2004
IPG39 Extracorporeal membrane oxygenation for severe acute respiratory failure in adults January 2004
IPG40 Non-surgical reduction of the myocardial septum February 2004
IPG41 Partial left ventriculectomy (the Batista procedure) February 2004
IPG42 Cyanoacrylate instillation for occlusion of parotid sinuses February 2004
IPG43 Needle fasciotomy for Dupuytren's contracture February 2004
IPG46 Laparoscopic pyeloplasty March 2004
IPG47 Photodynamic endometrial ablation March 2004
IPG49 Radiotherapy for age-related macular degeneration March 2004
IPG50 Vagus nerve stimulation for refractory epilepsy in children March 2004
IPG51 Free fluid thermal endometrial ablation March 2004
IPG52 Endovenous laser treatment of the long saphenous vein March 2004
IPG53 Computed tomography-guided thermocoagulation of osteoid osteoma March 2004
IPG55 Endoscopic injection of bulking agents for gastro-oesophageal reflux disease April 2004
IPG56 Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique) April 2004
IPG57 Laparoscopic live donor simple nephrectomy May 2004
IPG58 Transpupillary thermotherapy for age-related macular degeneration May 2004
IPG59 Subfascial endoscopic perforator vein surgery May 2004
IPG60 Thrombin injections for pseudoaneurysms May 2004
IPG61 Percutaneous endoscopic laser thoracic discectomy May 2004
IPG62 Falloposcopy with coaxial catheter June 2004
IPG63 Laser sheath removal of pacing leads June 2004
IPG64 Sacral nerve stimulation for urge incontinence and urgency-frequency June 2004
IPG65 Subthalamotomy for Parkinson's disease June 2004
IPG66 Artificial anal sphincter implantation June 2004
IPG67 Balloon dilatation of pulmonary valve stenosis June 2004
IPG68 Lumbar subcutaneous shunt June 2004
IPG69 Insertion of hydrogel keratoprosthesis June 2004
IPG70 Scleral expansion surgery for presbyopia July 2004
IPG71 Fallopian tube recanalisation by guidewire July 2004
IPG74 Balloon angioplasty with or without stenting for coarctation or recoarctation of the aorta in adults and children July 2004
IPG75 Balloon angioplasty of pulmonary vein stenosis in infants July 2004
IPG76 Balloon dilatation with or without stenting for pulmonary artery or non-valvar right ventricular outflow tract obstruction in children July 2004
IPG77 Balloon dilatation of systemic to pulmonary arterial shunts in children July 2004
IPG78 Balloon valvuloplasty for aortic valve stenosis in adults and children July 2004
IPG79 Stent placement for vena caval obstruction July 2004
IPG80 Selective peripheral denervation for cervical dystonia August 2004
IPG83 Percutaneous intradiscal radiofrequency thermocoagulation for lower back pain August 2004
IPG84 Supraorbital minicraniotomy for intracranial aneurysm August 2004
IPG85 Stereotactic radiosurgery for trigeminal neuralgia using the gamma knife August 2004
IPG86 Endovascular atrial septostomy August 2004
IPG87 Photodynamic therapy for advanced bronchial carcinoma August 2004
IPG89 Interstitial laser therapy for breast cancer September 2004
IPG90 Intralesional photocoagulation of subcutaneous congenital vascular disorders September 2004
IPG93 Selective internal radiation therapy for colorectal metastases of the liver September 2004
IPG95 Radiofrequency valvotomy for pulmonary atresia October 2004
IPG96 Endovascular closure of atrial septal defect October 2004
IPG97 Endovascular closure of patent ductus arteriosus October 2004
IPG98 Intraoperative fluorescence angiography for the evaluation of coronary artery bypass graft patency October 2004
IPG99 Sacral nerve stimulation for faecal incontinence November 2004
IPG101 Wireless capsule endoscopy for investigation of the small bowel December 2004
IPG103 Gastroelectrical stimulation for gastroparesis December 2004
IPG104 Impedance-controlled bipolar radiofrequency ablation for menorrhagia December 2004
IPG105 Coil embolisation of unruptured intracranial aneurysms January 2005
IPG106 Coil embolisation of ruptured intracranial aneurysms January 2005
IPG108 Auditory brain stem implants January 2005
IPG109 Percutaneous closure of patent foramen ovale for the prevention of cerebral embolic stroke January 2005
IPG110 Artificial metacarpophalangeal and interphalangeal joint replacement for end-stage arthritis February 2005
IPG111 Artificial trapeziometacarpal joint replacement for end-stage osteoarthritis February 2005
IPG113 Endoscopic dacryocystorhinostomy February 2005
IPG114 Lung volume reduction surgery for advanced emphysema February 2005
IPG115 Endoluminal gastroplication for gastro-oesophageal reflux disease February 2005
IPG118 High-intensity focused ultrasound for prostate cancer March 2005
IPG119 Cryotherapy for recurrent prostate cancer May 2005
IPG121 Radiofrequency ablation for atrial fibrillation in association with other cardiac surgery May 2005
IPG122 Microwave ablation for atrial fibrillation in association with other cardiac surgery May 2005
IPG123 Cryoablation for atrial fibrillation in association with other cardiac surgery May 2005
IPG124 Radiofrequency ablation of the soft palate for snoring May 2005
IPG126 Leukapheresis for inflammatory bowel disease June 2005
IPG127 Endovascular stent–graft placement in thoracic aortic aneurysms and dissections June 2005
IPG128 Totally endoscopic robotically assisted coronary artery bypass grafting June 2005
IPG129 Computed tomographic colonography (virtual colonoscopy) June 2005
IPG130 Collagen injection for vocal cord augmentation June 2005
IPG131 Interstitial laser therapy for fibroadenomas of the breast June 2005
IPG132 Low dose rate brachytherapy for localised prostate cancer July 2005
IPG133 Insertion of extraurethral (non-circumferential) retropubic adjustable compression devices for stress urinary incontinence in women July 2005
IPG134 Photodynamic therapy for bile duct cancer July 2005
IPG135 Laparoscopic liver resection July 2005
IPG136 Laparoscopic nephrectomy (including nephroureterectomy) August 2005
IPG137 Photodynamic therapy for localised inoperable endobronchial cancer November 2005
IPG138 Intramural urethral bulking procedures for stress urinary incontinence in women November 2005
IPG140 Metatarsophalangeal joint replacement of the hallux November 2005
IPG141 Automated percutaneous mechanical lumbar discectomy November 2005
IPG142 Cryotherapy for malignant endobronchial obstruction November 2005
IPG144 Intraoperative blood cell salvage in obstetrics November 2005
IPG145 Cryotherapy as a primary treatment for prostate cancer November 2005
IPG146 Direct C1 lateral mass screw for cervical spine stabilisation December 2005
IPG147 Endoscopic axillary lymph node retrieval for breast cancer December 2005
IPG148 Retrobulbar irradiation for thyroid eye disease December 2005
IPG149 Division of ankyloglossia (tongue-tie) for breastfeeding December 2005
IPG150 Electrosurgery (diathermy and coblation) for tonsillectomy December 2005
IPG151 Laparoscopic partial nephrectomy January 2006
IPG153 Foker technique for long-gap oesophageal atresia January 2006
IPG154 Insertion of biological slings for stress urinary incontinence in women January 2006
IPG155 Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) February 2006
IPG156 Image-guided vacuum-assisted excision biopsy of benign breast lesions February 2006
IPG157 Endometrial cryotherapy for menorrhagia March 2006
IPG158 Laparoscopic retroperitoneal lymph node dissection for testicular cancer March 2006
IPG159 Stimulated graciloplasty for faecal incontinence March 2006
IPG160 High dose rate brachytherapy for carcinoma of the cervix March 2006
IPG161 Percutaneous endoscopic colostomy March 2006
IPG162 Mosaicplasty for knee cartilage defects March 2006
IPG163 Stent-graft placement in abdominal aortic aneurysm March 2006
IPG164 Photorefractive (laser) surgery for the correction of refractive errors March 2006
IPG166 Balloon kyphoplasty for vertebral compression fractures April 2006
IPG167 Retrograde urethral sphincterometry April 2006
IPG168 Percutaneous radiofrequency ablation for atrial fibrillation April 2006
IPG170 Living-donor lung transplantation for end-stage lung disease May 2006
IPG171 Laparoscopic helium plasma coagulation for the treatment of endometriosis May 2006
IPG173 Percutaneous disc decompression using coblation for lower back pain May 2006
IPG174 High dose rate brachytherapy in combination with external-beam radiotherapy for localised prostate cancer May 2006
IPG175 Percutaneous fetal balloon valvuloplasty for aortic stenosis May 2006
IPG176 Percutaneous fetal balloon valvuloplasty for pulmonary atresia with intact ventricular septum May 2006
IPG177 Short-term circulatory support with left ventricular assist devices as a bridge to cardiac transplantation or recovery June 2006
IPG178 Tonsillectomy using ultrasonic scalpel June 2006
IPG179 Percutaneous cementoplasty for palliative treatment of bony malignancies June 2006
IPG180 Percutaneous laser therapy for fetal tumours June 2006
IPG184 High-intensity focused ultrasound for atrial fibrillation in association with other cardiac surgery July 2006
IPG186 Tonsillectomy using laser July 2006
IPG187 Catheterless oesophageal pH monitoring July 2006
IPG188 Deep brain stimulation for tremor and dystonia (excluding Parkinson's disease) August 2006
IPG189 Minimally invasive oesophagectomy for cancer or high-grade dysplasia of the oesophagus August 2006
IPG190 Insertion of pleuro–amniotic shunt for fetal pleural effusion September 2006
IPG191 Carotid artery stent placement for symptomatic extracranial carotid stenosis September 2006
IPG192 Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) November 2006
IPG193 Laparoscopic radical prostatectomy November 2006
IPG194 Living-donor liver transplantation November 2006
IPG196 Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures November 2006
IPG197 Intramedullary distraction for lower limb lengthening December 2006
IPG198 Intrauterine laser ablation of placental vessels for the treatment of twin-to-twin transfusion syndrome December 2006
IPG199 Septostomy with or without amnioreduction for the treatment of twin-to-twin transfusion syndrome December 2006
IPG200 Photodynamic therapy for early-stage oesophageal cancer December 2006
IPG201 Preoperative high dose rate brachytherapy for rectal cancer December 2006
IPG202 Fetal vesico–amniotic shunt for lower urinary tract outflow obstruction December 2006
IPG203 Open femoro-acetabular surgery for hip impingement syndrome January 2007
IPG204 Laparoscopic distal pancreatectomy January 2007
IPG205 Fetal cystoscopy for the diagnosis and treatment of lower urinary outflow tract obstruction January 2007
IPG206 Palliative photodynamic therapy for advanced oesophageal cancer January 2007
IPG207 Laparoscopic cryotherapy for renal cancer January 2007
IPG208 Laparoscopic insertion of peritoneal dialysis catheter February 2007
IPG209 Implantation of accommodating intraocular lenses for cataract February 2007
IPG210 Injectable bulking agents for faecal incontinence February 2007
IPG211 Radiofrequency-assisted liver resection February 2007
IPG212 Laparoscopic nephrolithotomy and pyelolithotomy March 2007
IPG213 Arthroscopic femoro–acetabular surgery for hip impingement syndrome March 2007
IPG214 Microwave ablation of hepatocellular carcinoma March 2007
IPG216 Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium April 2007
IPG218 Therapeutic sialendoscopy May 2007
IPG219 Lower limb deep vein valve reconstruction for chronic deep venous incompetence May 2007
IPG220 Microwave ablation for the treatment of metastases in the liver May 2007
IPG221 Closure of anal fistula using a suturable bioprosthetic plug June 2007
IPG222 Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease June 2007
IPG223 Therapeutic percutaneous image-guided aspiration of spinal cysts August 2007
IPG225 Corneal implants for the correction of refractive error July 2007
IPG226 Laparoscopic deroofing of simple renal cysts July 2007
IPG227 Corneal implants for keratoconus July 2007
IPG228 Laparoscopic cerclage for prevention of recurrent pregnancy loss due to cervical incompetence August 2007
IPG229 Laparoscopic repair of abdominal aortic aneurysm August 2007
IPG230 Arthroscopic knee washout, with or without debridement, for the treatment of osteoarthritis August 2007
IPG231 Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids September 2007
IPG232 Serial transverse enteroplasty procedure (STEP) for bowel lengthening in parenteral nutrition-dependent children September 2007
IPG233 Endovascular stent insertion for intracranial atherosclerotic disease October 2007
IPG234 Laparoscopic uterine nerve ablation (LUNA) for chronic pelvic pain October 2007
IPG235 Intravesical microwave hyperthermia with intravesical chemotherapy for superficial bladder cancer October 2007
IPG236 Grenz rays therapy for inflammatory skin conditions November 2007
IPG237 Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction November 2007
IPG238 Mini/micro screw implantation for orthodontic anchorage November 2007
IPG239 Laparoscopic techniques for hysterectomy November 2007
IPG240 Soft-palate implants for simple snoring November 2007
IPG241 Soft-palate implants for obstructive sleep apnoea November 2007
IPG242 Transcranial magnetic stimulation for severe depression November 2007
IPG243 Thoracoscopic aortopexy for severe primary tracheomalacia December 2007
IPG245 Thoracoscopically assisted mitral valve surgery December 2007
IPG246 Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates December 2007
IPG247 Thoracoscopic excision of mediastinal parathyroid tumours December 2007
IPG249 Ultrasound-guided catheterisation of the epidural space January 2008
IPG250 Arteriovenous extracorporeal membrane carbon dioxide removal January 2008
IPG251 Liposuction for chronic lymphoedema February 2008
IPG252 Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion February 2008
IPG253 Laparoscopic mobilisation of the greater omentum for breast reconstruction February 2008
IPG254 Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses February 2008
IPG255 Intraoperative nerve monitoring during thyroid surgery March 2008
IPG257 Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus April 2008
IPG258 Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy April 2008
IPG259 Interstitial photodynamic therapy for malignant parotid tumours April 2008
IPG260 Canaloplasty for primary open-angle glaucoma May 2008
IPG261 Endoaortic balloon occlusion for cardiac surgery May 2008
IPG262 Single-incision sub-urethral short tape insertion for stress urinary incontinence in women May 2008
IPG263 Lumbar infusion test for the investigation of normal pressure hydrocephalus June 2008
IPG264 Implantation of multifocal (non-accommodative) intraocular lenses during cataract surgery June 2008
IPG265 Stent insertion for bleeding oesophageal varices June 2008
IPG266 Transcatheter aortic valve implantation for aortic stenosis June 2008
IPG267 Surgical repair of vaginal wall prolapse using mesh June 2008
IPG268 Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision July 2008
IPG269 Laparoscopic gastrectomy for cancer July 2008
IPG270 Direct skeletal fixation of limb or digit prostheses using intraosseous transcutaneous implants July 2008
IPG271 Total wrist replacement August 2008
IPG272 Implantation of miniature lens systems for advanced age-related macular degeneration August 2008
IPG273 Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis September 2008
IPG274 Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy September 2008
IPG275 Laparoscopic prostatectomy for benign prostatic obstruction November 2008
IPG276 Transabdominal artificial bowel sphincter implantation for faecal incontinence November 2008
IPG277 Electrically-stimulated intravesical chemotherapy for superficial bladder cancer November 2008
IPG278 Functional electrical stimulation for drop foot of central neurological origin January 2009
IPG279 Autologous blood injection for tendinopathy January 2009
IPG280 Infracoccygeal sacropexy using mesh for uterine prolapse repair January 2009
IPG281 Infracoccygeal sacropexy using mesh for vaginal vault prolapse repair January 2009
IPG282 Insertion of mesh uterine suspension sling (including sacrohysteropexy) for uterine prolapse repair January 2009
IPG283 Sacrocolpopexy using mesh for vaginal vault prolapse repair January 2009
IPG284 Sacrocolpopexy with hysterectomy using mesh for uterine prolapse repair January 2009
IPG285 Ultrasound-guided regional nerve block January 2009
IPG286 Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation January 2009
IPG287 Laparoscopic cystectomy February 2009
IPG288 Extracorporeal photopheresis for Crohn's disease February 2009
IPG289 Intraocular lens insertion for correction of refractive error, with preservation of the natural lens February 2009
IPG290 Photodynamic therapy for brain tumours March 2009
IPG291 Deep dermal injection of non-absorbable gel polymer for HIV-related facial lipoatrophy March 2009
IPG292 Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease August 2013
IPG293 Implantation of an opaque intraocular lens for intractable double vision March 2009
IPG294 Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation March 2009
IPG295 Percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for ventricular tachycardia March 2009
IPG296 Endoscopic mastectomy and endoscopic wide local excision for breast cancer April 2009
IPG297 Combined bony and soft tissue reconstruction for hip joint stabilisation in proximal focal femoral deficiency (PFFD) April 2009
IPG298 Ex-vivo hepatic resection and reimplantation for liver cancer April 2009
IPG299 Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) May 2009
IPG300 Percutaneous endoscopic laser lumbar discectomy May 2009
IPG301 Transmyocardial laser revascularisation for refractory angina pectoris May 2009
IPG302 Percutaneous laser revascularisation for refractory angina pectoris May 2009
IPG303 Percutaneous endoscopic laser cervical discectomy June 2009
IPG304 Corneal endothelial transplantation June 2009
IPG305 Sinus tarsi implant insertion for mobile flatfoot July 2009
IPG306 Prosthetic intervertebral disc replacement in the lumbar spine July 2009
IPG307 Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure due to neurological disease July 2009
IPG308 Image-guided radiofrequency excision biopsy of breast lesions July 2009
IPG309 Percutaneous mitral valve leaflet repair for mitral regurgitation August 2009
IPG310 Placement of pectus bar for pectus excavatum (also known as MIRPE or the Nuss procedure) August 2009
IPG311 Extracorporeal shockwave therapy for refractory plantar fasciitis August 2009
IPG312 Extracorporeal shockwave therapy for refractory Achilles tendinopathy August 2009
IPG313 Extracorporeal shockwave therapy for refractory tennis elbow August 2009
IPG314 Ultrasound-guided foam sclerotherapy for varicose veins August 2009
IPG315 Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants September 2009
IPG316 Extracorporeal albumin dialysis for acute liver failure September 2009
IPG317 Individually magnetic resonance imaging-designed unicompartmental interpositional implant insertion for osteoarthritis of the knee September 2009
IPG318 Bronchoscopic lung volume reduction with airway valves for advanced emphysema November 2009
IPG319 Percutaneous intradiscal electrothermal therapy for low back pain November 2009
IPG320 Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus November 2009
IPG321 Lateral (including extreme, extra and direct lateral) interbody fusion in the lumbar spine November 2009
IPG322 Negative pressure wound therapy for the open abdomen December 2009
IPG323 Balloon catheter insertion for Bartholin's cyst or abscess December 2009
IPG324 Electrocautery cutting balloon treatment for pelviureteric junction obstruction December 2009
IPG325 Endopyelotomy for pelviureteric junction obstruction December 2009
IPG326 Laparoscopic augmentation cystoplasty (including clam cystoplasty) December 2009
IPG327 Radiofrequency ablation for colorectal liver metastases December 2009
IPG328 Suction diathermy adenoidectomy December 2009
IPG329 Total prosthetic replacement of the temporomandibular joint December 2009
IPG330 Vagus nerve stimulation for treatment-resistant depression December 2009
IPG331 Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis February 2010
IPG332 Surgical correction of hallux valgus using minimal access techniques February 2010
IPG333 Therapeutic endoscopic division of epidural adhesions February 2010
IPG334 Arteriovenous crossing sheathotomy for branch retinal vein occlusion March 2010
IPG335 Endoscopic submucosal dissection of lower gastrointestinal lesions March 2010
IPG336 Transcatheter endovascular closure of perimembranous ventricular septal defect March 2010
IPG337 Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions March 2010
IPG338 Laparoscopic radical hysterectomy for early stage cervical cancer May 2010
IPG339 Limited macular translocation for wet age-related macular degeneration May 2010
IPG340 Macular translocation with 360° retinotomy for wet age-related macular degeneration May 2010
IPG341 Prosthetic intervertebral disc replacement in the cervical spine May 2010
IPG342 Haemorrhoidal artery ligation May 2010
IPG343 Endoscopic saphenous vein harvest for coronary artery bypass grafting May 2010
IPG344 Epithelial radiofrequency ablation for Barrett's oesophagus May 2010
IPG345 Mini-incision surgery for total knee replacement May 2010
IPG346 Single-incision laparoscopic cholecystectomy May 2010
IPG347 Therapeutic hypothermia with intracorporeal temperature monitoring for hypoxic perinatal brain injury May 2010
IPG348 Extracranial to intracranial bypass for intracranial atherosclerosis June 2010
IPG349 Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism June 2010
IPG350 Photodynamic therapy for Barrett's oesophagus June 2010
IPG351 Stapled transanal rectal resection for obstructed defaecation syndrome June 2010
IPG352 Percutaneous mitral valve annuloplasty July 2010
IPG353 Percutaneous radiofrequency ablation for renal cancer July 2010
IPG354 Shoulder resurfacing arthroplasty July 2010
IPG355 Endoscopic submucosal dissection of oesophageal dysplasia and neoplasia September 2010
IPG356 Laparoscopic hysterectomy (including laparoscopic total hysterectomy and laparoscopically assisted vaginal hysterectomy) for endometrial cancer September 2010
IPG357 Percutaneous intradiscal laser ablation in the lumbar spine September 2010
IPG358 Phototherapeutic laser keratectomy for corneal surface irregularities September 2010
IPG359 Endoscopic mucosal resection and endoscopic submucosal dissection of non-ampullary duodenal lesions October 2010
IPG360 Endoscopic submucosal dissection of gastric lesions October 2010
IPG361 Insertion of metal rib reinforcements to stabilise a flail chest wall October 2010
IPG362 Percutaneous posterior tibial nerve stimulation for overactive bladder syndrome October 2010
IPG363 Minimally invasive total hip replacement October 2010
IPG364 Transperineal template biopsy and mapping of the prostate October 2010
IPG365 Interspinous distraction procedures for lumbar spinal stenosis causing neurogenic claudication November 2010
IPG366 Non rigid stabilisation techniques for the treatment of low back pain November 2010
IPG367 Uterine artery embolisation for fibroids November 2010
IPG368 Radiation therapy for early Dupuytren's disease November 2010
IPG369 Cryotherapy for the treatment of liver metastases December 2010
IPG370 Percutaneous closure of patent foramen ovale for recurrent migraine December 2010
IPG371 Percutaneous closure of patent foramen ovale for the secondary prevention of recurrent paradoxical embolism in divers December 2010
IPG372 Percutaneous radiofrequency ablation for primary or secondary lung cancers December 2010
IPG373 Selective dorsal rhizotomy for spasticity in cerebral palsy December 2010
IPG374 Low-intensity pulsed ultrasound to promote fracture healing December 2010
IPG375 Distal iliotibial band lengthening for refractory greater trochanteric pain syndrome January 2011
IPG376 Extracorporeal shockwave therapy for refractory greater trochanteric pain syndrome January 2011
IPG377 Off-pump coronary artery bypass grafting January 2011
IPG378 Percutaneous laser coronary angioplasty January 2011
IPG379 Thoracoscopic repair of congenital diaphragmatic hernia in neonates January 2011
IPG380 Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices February 2011
IPG381 Deep brain stimulation for intractable trigeminal autonomic cephalalgias March 2011
IPG382 Deep brain stimulation for refractory chronic pain syndromes (excluding headache) March 2011
IPG383 Hand allotransplantation March 2011
IPG384 Percutaneous retroperitoneal endoscopic necrosectomy March 2011
IPG385 Laser correction of refractive error following non-refractive ophthalmic surgery March 2011
IPG386 Therapeutic hypothermia following cardiac arrest March 2011
IPG387 Transaxial interbody lumbosacral fusion March 2011
IPG388 Carotid artery stent placement for asymptomatic extracranial carotid stenosis April 2011
IPG389 Carotid artery stent placement for symptomatic extracranial carotid stenosis April 2011
IPG390 Endovascular stent-grafting of popliteal aneurysms April 2011
IPG391 Extracorporeal membrane oxygenation for severe acute respiratory failure in adults April 2011
IPG392 Stent insertion for bleeding oesophageal varices April 2011
IPG393 Endoscopic radiofrequency therapy of the anal sphincter for faecal incontinence May 2011
IPG394 External aortic root support in Marfan syndrome May 2011
IPG395 Percutaneous tibial nerve stimulation for faecal incontinence May 2011
IPG396 Trabecular stent bypass microsurgery for open angle glaucoma May 2011
IPG397 Trabeculotomy ab interno for open angle glaucoma May 2011
IPG398 Endoscopic radical inguinal lymphadenectomy June 2011
IPG399 Percutaneous endoscopic catheter laser balloon pulmonary vein isolation for atrial fibrillation June 2011
IPG400 Thoracoscopic exclusion of the left atrial appendage (with or without surgical ablation) for non-valvular atrial fibrillation for the prevention of thromboembolism June 2011
IPG401 Selective internal radiation therapy for non-resectable colorectal metastases in the liver May 2013
IPG402 Percutaneous cryotherapy for renal cancer July 2011
IPG403 Open femoro–acetabular surgery for hip impingement syndrome July 2011
IPG404 Endoluminal gastroplication for gastro-oesophageal reflux disease July 2011
IPG405 Laparoscopic cryotherapy for renal cancer August 2011
IPG406 Microwave ablation for the treatment of liver metastases August 2011
IPG407 Minimally invasive oesophagectomy September 2011
IPG408 Arthroscopic femoro–acetabular surgery for hip impingement syndrome September 2011
IPG409 Balloon dilatation of the Eustachian tube November 2011
IPG410 Closure of anal fistula using a suturable bioprosthetic plug November 2011
IPG411 Endoscopic transluminal pancreatic necrosectomy November 2011
IPG412 Drainage, irrigation and fibrinolytic therapy (DRIFT) for post-haemorrhagic hydrocephalus in preterm infants November 2011
IPG413 Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids November 2011
IPG414 Single-port laparoscopic nephrectomy November 2011
IPG415 Epiretinal brachytherapy for wet age-related macular degeneration December 2011
IPG416 Deep brain stimulation for refractory epilepsy January 2012
IPG417 Breast reconstruction using lipomodelling after breast cancer treatment January 2012
IPG418 Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for resistant hypertension January 2012
IPG419 Bronchial thermoplasty for severe asthma January 2012
IPG420 Percutaneous venoplasty for chronic cerebrospinal venous insufficiency for multiple sclerosis March 2012
IPG421 Transcatheter aortic valve implantation for aortic stenosis March 2012
IPG422 Incisionless otoplasty March 2012
IPG423 Focal therapy using cryoablation for localised prostate cancer April 2012
IPG424 Focal therapy using high-intensity focused ultrasound for localised prostate cancer April 2012
IPG425 Endoscopic balloon dilatation for subglottic or tracheal stenosis April 2012
IPG426 Micropressure therapy for refractory Ménière's disease April 2012
IPG427 Percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation May 2012
IPG428 Extracorporeal membrane carbon dioxide removal June 2012
IPG429 Endovascular stent insertion for intracranial atherosclerotic disease July 2012
IPG430 Partial replacement of the meniscus of the knee using a biodegradable scaffold July 2012
IPG431 Laparoscopic insertion of a magnetic bead band for gastro-oesophageal reflux disease September 2012
IPG432 Laparoscopic gastric plication for the treatment of severe obesity November 2012
IPG433 Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease November 2012
IPG434 Radiofrequency cold ablation for respiratory papillomatosis November 2012
IPG435 Endovenous mechanochemical ablation for varicose veins January 2013
IPG436 Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction January 2013
IPG437 Autologous blood injection for plantar fasciitis January 2013
IPG438 Autologous blood injection for tendinopathy January 2013
IPG439 Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy January 2013
IPG440 Ultrasound-guided foam sclerotherapy for varicose veins February 2013
IPG441 Irreversible electroporation for treating primary lung cancer and metastases in the lung February 2013
IPG442 Irreversible electroporation for treating pancreatic cancer February 2013
IPG443 Irreversible electroporation for treating renal cancer February 2013
IPG444 Irreversible electroporation for treating primary liver cancer February 2013
IPG445 Irreversible electroporation for treating liver metastases February 2013
IPG446 Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma March 2013
IPG447 Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma March 2013
IPG448 Insertion of endobronchial valves for persistent air leaks March 2013
IPG449 Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction July 2013
IPG450 Percutaneous electrical nerve stimulation for refractory neuropathic pain March 2013
IPG451 Peripheral nerve-field stimulation for chronic low back pain March 2013
IPG452 Occipital nerve stimulation for intractable chronic migraine April 2013
IPG453 Prostate artery embolisation for benign prostatic hyperplasia April 2013
IPG454 Insertion of a subcutaneous implantable cardioverter defibrillator for prevention of sudden cardiac death April 2013
IPG455 Corneal inlay implantation for correction of presbyopia April 2013
IPG456 Sutureless aortic valve replacement for aortic stenosis July 2013
IPG457 Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction July 2013
IPG458 Mechanical clot retrieval for treating acute ischaemic stroke July 2013
IPG459 Selective internal radiation therapy for primary intrahepatic cholangiocarcinoma July 2013
IPG460 Selective internal radiation therapy for primary hepatocellular carcinoma July 2013
IPG461 Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease August 2013
IPG462 Translaryngeal tracheostomy August 2013
IPG463 Insertion and use of implantable pulmonary artery pressure monitors in chronic heart failure August 2013
IPG464 Endoscopic bipolar radiofrequency ablation for treating biliary obstruction caused by cholangiocarcinoma or pancreatic adenocarcinoma September 2013
IPG465 Insertion of endobronchial valves for lung volume reduction in emphysema September 2013
IPG466 Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia September 2013
IPG467 Negative pressure wound therapy for the open abdomen November 2013
IPG468 Phrenic nerve transfer in brachial plexus injury November 2013
IPG469 Microwave ablation for treating primary lung cancer and metastases in the lung November 2013
IPG470 Ultra-radical (extensive) surgery for advanced ovarian cancer November 2013
IPG471 Implantation of a duodenal–jejunal bypass sleeve for managing obesity November 2013
IPG472 Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events December 2013
IPG473 Uterine artery embolisation for treating adenomyosis December 2013
IPG474 Arthroscopic trochleoplasty for patellar instability January 2014
IPG475 Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia January 2014
IPG476 Radiofrequency ablation of the soft palate for snoring January 2014
IPG477 Transcranial magnetic stimulation for treating and preventing migraine January 2014
IPG478 Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma February 2014
IPG479 Subcutaneous implantation of a battery-powered catheter drainage system for managing refractory and recurrent ascites February 2014
IPG480 Endoscopic thoracic sympathectomy for primary facial blushing February 2014
IPG481 Optical coherence tomography to guide percutaneous coronary intervention February 2014
IPG482 Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults March 2014
IPG483 Insertion of a magnetic bead band for faecal incontinence March 2014
IPG484 Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy March 2014
IPG485 Faecal microbiota transplant for recurrent Clostridium difficile infection March 2014
IPG486 Hysteroscopic morcellation of uterine fibroids April 2014
IPG487 Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb May 2014
IPG488 Chemosaturation via percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic liver cancer May 2014
IPG489 Gastroelectrical stimulation for gastroparesis May 2014
IPG490 Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia May 2014
IPG491 Platelet-rich plasma injections for osteoarthritis of the knee May 2014
IPG492 Bioresorbable stent implantation for treating coronary artery disease May 2014
IPG493 Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee June 2014
IPG494 Endoscopic saphenous vein harvest for coronary artery bypass grafting June 2014
IPG495 Radiofrequency tissue reduction for turbinate hypertrophy June 2014
IPG496 Endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia or no dysplasia July 2014
IPG497 Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus July 2014
IPG498 Powered microdebrider turbinoplasty for inferior turbinate hypertrophy July 2014

Key therapeutic topics

Ref Title Date issued
KTT1 Laxatives January 2013
KTT2 Renin-angiotensin system drugs January 2013
KTT3 Lipid modifying drugs including ezetimibe January 2013
KTT4 Omega-3 fatty acid supplements January 2013
KTT5 High-dose inhaled corticosteroids in asthma January 2013
KTT6 Hypnotics January 2013
KTT7 Low-dose antipsychotics in people with dementia January 2013
KTT8 First-choice antidepressant use in adults with depression or generalised anxiety disorder January 2013
KTT9 Antibiotic prescribing – especially quinolones and cephalosporins January 2013
KTT10 Three-day courses of trimethoprim for uncomplicated urinary tract infection January 2013
KTT11 Minocycline January 2013
KTT12 Type 2 diabetes mellitus January 2013
KTT13 Non-steroidal anti-inflammatory drugs January 2013
KTT14 Wound care products January 2013

NICE local government briefings

Ref Title Date issued
LGB1 Tobacco July 2012
LGB2 Workplace health July 2012
LGB3 Physical activity April 2013
LGB4 Health inequalities and population health October 2012
LGB5 NICE guidance and public health outcomes October 2012
LGB6 Alcohol October 2012
LGB7 Behaviour change January 2013
LGB8 Walking and cycling January 2013
LGB9 Preventing obesity and helping people to manage their weight May 2013
LGB10 Judging whether public health interventions offer value for money September 2013
LGB10B How NICE measures value for money in relation to public health interventions September 2013
LGB11 Tuberculosis in vulnerable groups September 2013
LGB12 Social and emotional wellbeing for children and young people September 2013
LGB13 Body mass index thresholds for intervening to prevent ill health among black, Asian and other minority ethnic groups January 2014
LGB14 Improving access to health and social care services for people who do not routinely use them January 2014
LGB15 Encouraging people to have NHS Health Checks and supporting them to reduce risk factors February 2014
LGB16 Community engagement to improve health March 2014
LGB17 Contraceptive services March 2014
LGB18 Tackling drug use May 2014
LGB19 Looked-after children and young people June 2014
LGB20 Domestic violence and abuse: how services can respond effectively June 2014
LGB21 HIV testing June 2014

Medtech innovation briefing

Ref Title Date issued
MIB1 The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burns February 2014
MIB2 The PressureWire fractional flow reserve measurement system for coronary artery disease February 2014
MIB3 The NGAL Test for early diagnosis of acute kidney injury February 2014
MIB4 The RhinoChill intranasal cooling system for reducing temperature after cardiac arrest February 2014
MIB5 Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitus June 2014
MIB6 AccuVein AV400 for vein visualisation June 2014

Medicines practice guidelines

Ref Title Date issued
MPG1 Developing and updating local formularies February 2014
MPG2 Patient Group Directions February 2014

NICE medical technology guidance

Ref Title Date issued
MTG1 SeQuent Please balloon catheter for in-stent coronary restenosis December 2010
MTG2 moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment March 2011
MTG3 CardioQ-ODM oesophageal doppler monitor March 2011
MTG4 BRAHMS copeptin assay to rule out myocardial infarction in patients with acute chest pain June 2011
MTG5 The MIST Therapy system for the promotion of wound healing July 2011
MTG6 Ambulight PDT for the treatment of non-melanoma skin cancer July 2011
MTG7 Inditherm patient warming mattress for the prevention of inadvertent hypothermia August 2011
MTG8 The VeriQ system for assessing graft flow during coronary artery bypass graft surgery November 2011
MTG9 The PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites March 2012
MTG10 Pipeline embolisation device for the treatment of complex intracranial aneurysms May 2012
MTG11 Mega Soft Patient Return Electrode for use during monopolar electrosurgery August 2012
MTG12 EXOGEN ultrasound bone healing system for long bone fractures with non-union or delayed healing January 2013
MTG13 WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension January 2013
MTG14 Ambu aScope2 for use in unexpected difficult airways July 2013
MTG15 Vision Amniotic Leak Detector to assess unexplained vaginal wetness in pregnancy July 2013
MTG16 The E‑vita open plus for treating complex aneurysms and dissections of the thoracic aorta December 2013
MTG17 The Debrisoft monofilament debridement pad for use in acute or chronic wounds March 2014
MTG18 The MAGEC system for spinal lengthening in children with scoliosis June 2014
MTG19 The geko device for reducing the risk of venous thromboembolism June 2014

Into practice

Ref Title Date issued
PG1 Into practice guide: Using NICE guidance and quality standards to improve practice May 2014

NICE public health guidance

Ref Title Date issued
PH1 Brief interventions and referral for smoking cessation March 2006
PH2 Four commonly used methods to increase physical activity May 2013
PH3 Prevention of sexually transmitted infections and under 18 conceptions February 2007
PH4 Interventions to reduce substance misuse among vulnerable young people March 2007
PH5 Workplace interventions to promote smoking cessation April 2007
PH6 Behaviour change: the principles for effective interventions October 2007
PH7 School-based interventions on alcohol November 2007
PH8 Physical activity and the environment January 2008
PH9 Community engagement February 2008
PH10 Smoking cessation services November 2013
PH11 Maternal and child nutrition March 2008
PH12 Social and emotional wellbeing in primary education March 2008
PH13 Promoting physical activity in the workplace May 2008
PH14 Preventing the uptake of smoking by children and young people July 2008
PH15 Identifying and supporting people most at risk of dying prematurely September 2008
PH16 Occupational therapy and physical activity interventions to promote the mental wellbeing of older people in primary care and residential care October 2008
PH17 Promoting physical activity for children and young people January 2009
PH18 Needle and syringe programmes February 2009
PH19 Managing long-term sickness and incapacity for work March 2009
PH20 Social and emotional wellbeing in secondary education September 2009
PH21 Reducing differences in the uptake of immunisations September 2009
PH22 Promoting mental wellbeing at work November 2009
PH23 School-based interventions to prevent smoking February 2010
PH24 Alcohol-use disorders: preventing harmful drinking June 2010
PH25 Prevention of cardiovascular disease June 2010
PH26 Quitting smoking in pregnancy and following childbirth June 2010
PH27 Weight management before, during and after pregnancy July 2010
PH28 Looked-after children and young people April 2013
PH29 Strategies to prevent unintentional injuries among the under-15s November 2010
PH30 Preventing unintentional injuries among the under-15s in the home November 2010
PH31 Preventing unintentional road injuries among under-15s November 2010
PH32 Skin cancer prevention: information, resources and environmental changes January 2011
PH33 Increasing the uptake of HIV testing among black Africans in England March 2011
PH34 Increasing the uptake of HIV testing among men who have sex with men March 2011
PH35 Preventing type 2 diabetes: population and community-level interventions May 2011
PH36 Prevention and control of healthcare-associated infections November 2011
PH37 Identifying and managing tuberculosis among hard-to-reach groups March 2012
PH38 Preventing type 2 diabetes: risk identification and interventions for individuals at high risk July 2012
PH39 Smokeless tobacco cessation: South Asian communities September 2012
PH40 Social and emotional wellbeing: early years October 2012
PH41 Walking and cycling: local measures to promote walking and cycling as forms of travel or recreation November 2012
PH42 Obesity: working with local communities November 2012
PH43 Hepatitis B and C: ways to promote and offer testing to people at increased risk of infection March 2013
PH44 Physical activity: brief advice for adults in primary care May 2013
PH45 Tobacco: harm-reduction approaches to smoking July 2013
PH46 Assessing body mass index and waist circumference thresholds for intervening to prevent ill health and premature death among adults from black, Asian and other minority ethnic groups in the UK July 2013
PH47 Managing overweight and obesity among children and young people: lifestyle weight management services October 2013
PH48 Smoking cessation in secondary care: acute, maternity and mental health services November 2013
PH49 Behaviour change: individual approaches January 2014
PH50 Domestic violence and abuse: how health services, social care and the organisations they work with can respond effectively February 2014
PH51 Contraceptive services with a focus on young people up to the age of 25 March 2014
PH52 Needle and syringe programmes March 2014
PH53 Managing overweight and obesity in adults – lifestyle weight management services May 2014

Local government public health briefings

Ref Title Date issued
PHB1 Tobacco July 2012
PHB2 Workplace health July 2012
PHB3 Workplace health July 2012
PHB4 Health inequalities and population health October 2012
PHB5 NICE guidance and public health outcomes October 2012
PHB6 Alcohol October 2012
PHB7 Behaviour change January 2013
PHB8 Walking and cycling January 2013
PHB9 Preventing obesity and helping people to manage their weight May 2013

Process and methods guides

Ref Title Date issued
PMG1 Evidence summaries: new medicines – Interim process statement June 2012
PMG2 Evidence summaries: unlicensed and off-label medicines – Interim process statement August 2012
PMG3 Good practice guidance – Interim process statement August 2012
PMG4 Methods for the development of NICE public health guidance (third edition) September 2012
PMG5 The NICE public health guidance development process (third edition) September 2012
PMG6 The guidelines manual November 2012
PMG6A The guidelines manual: appendix A – agreements and advice for Guideline Development Group members November 2012
PMG6C The guidelines manual: appendices J–K November 2012
PMG6D The guidelines manual: appendix L – Abbreviations and glossary November 2012
PMG6E The guidelines manual: appendix M – Guide to the short clinical guideline process November 2012
PMG6F How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS November 2012
PMG6B The guidelines manual: appendices B–I November 2012
PMG7 Key therapeutic topics – Medicines management options for local implementation: Interim process statement January 2013
PMG8 Interim methods guide for developing service guidance February 2013
PMG9 Guide to the methods of technology appraisal 2013 April 2013
PMG10 The social care guidance manual April 2013
PMG11 Evidence summaries: new medicines – Integrated process statement May 2013
PMG12 Good practice guidance – Integrated process statement May 2013
PMG13 Medicines management options for local implementation – Integrated process statement May 2013
PMG14 Evidence summaries: unlicensed and off-label medicines – Integrated process statement May 2013
PMG15 Interim methods guide for developing good practice guidance August 2013
PMG16 Interim clinical guideline surveillance process and methods guide 2013 August 2013
PMG17 Interim process and methods guide for the clinical guideline updates using standing committees pilot programme 2013 May 2014
PMG18 Guide to the technology appraisal and highly specialised technologies appeal process February 2014

Quality Standards

Ref Title Date issued
QS1 Dementia quality standard June 2010
QS2 Stroke quality standard June 2010
QS3 Venous thromboembolism prevention quality standard June 2010
QS4 Specialist neonatal care quality standard October 2010
QS5 Chronic kidney disease quality standard March 2011
QS6 Diabetes in adults quality standard March 2011
QS7 Glaucoma quality standard March 2011
QS8 Depression in adults quality standard March 2011
QS9 Chronic heart failure quality standard June 2011
QS10 Chronic obstructive pulmonary disease quality standard July 2011
QS11 Alcohol dependence and harmful alcohol use quality standard August 2011
QS12 Breast cancer quality standard September 2011
QS13 Quality standard for end of life care for adults October 2013
QS14 Quality standard for service user experience in adult mental health December 2011
QS15 Quality standard for patient experience in adult NHS services February 2012
QS16 Quality standard for hip fracture March 2012
QS17 Quality standard for lung cancer March 2012
QS18 Quality standard for ovarian cancer May 2012
QS19 Quality standard for bacterial meningitis and meningococcal septicaemia in children and young people June 2012
QS20 Quality standard for colorectal cancer August 2012
QS21 Quality standard for stable angina August 2012
QS22 Quality standard for antenatal care September 2012
QS23 Quality standard for drug use disorders November 2012
QS24 Quality standard for nutrition support in adults November 2012
QS25 Quality standard for asthma February 2013
QS26 Quality standard for the epilepsies in adults February 2013
QS27 Quality standard for the epilepsies in children and young people February 2013
QS28 Quality standard for hypertension March 2013
QS29 Quality standard for diagnosis and management of venous thromboembolic diseases March 2013
QS30 Quality standard for supporting people to live well with dementia April 2013
QS31 Quality standard for the health and wellbeing of looked-after children and young people April 2013
QS32 Quality standard for caesarean section June 2013
QS33 Quality standard for rheumatoid arthritis June 2013
QS34 Quality standard for self‑harm June 2013
QS35 Hypertension in pregnancy July 2013
QS36 Urinary tract infection in infants, children and young people under 16 July 2013
QS37 Postnatal care July 2013
QS38 Acute upper gastrointestinal bleeding July 2013
QS39 Attention deficit hyperactivity disorder July 2013
QS40 Psoriasis August 2013
QS41 Familial hypercholesterolaemia August 2013
QS42 Headaches in young people and adults August 2013
QS43 Smoking cessation: supporting people to stop smoking August 2013
QS44 Atopic eczema in children September 2013
QS45 Lower urinary tract symptoms in men September 2013
QS46 Multiple pregnancy September 2013
QS47 Heavy menstrual bleeding September 2013
QS48 Depression in children and young people September 2013
QS49 Surgical site infection October 2013
QS50 Mental wellbeing of older people in care homes December 2013
QS51 Autism January 2014
QS52 Peripheral arterial disease January 2014
QS53 Anxiety disorders February 2014
QS54 Faecal incontinence February 2014
QS55 Children and young people with cancer February 2014
QS56 Metastatic spinal cord compression February 2014
QS57 Neonatal jaundice March 2014
QS58 Sickle cell acute painful episode April 2014
QS59 Antisocial behaviour and conduct disorders in children and young people April 2014
QS60 Induction of labour April 2014
QS61 Infection prevention and control April 2014
QS62 Constipation in children and young people May 2014

Guideline

Ref Title Date issued
SC1 Managing medicines in care homes March 2014

Guideline IFP

Ref Title Date issued
SCIFP1 Managing medicines in care homes March 2014

Safe staffing guideline

Ref Title Date issued
SG1 Safe staffing for nursing in adult inpatient wards in acute hospitals July 2014

NICE technology appraisal guidance

Ref Title Date issued
TA1 Guidance on the Extraction of Wisdom Teeth March 2000
TA2 Guidance on the Selection of Prostheses for Primary Total Hip Replacement April 2000
TA3 Ovarian cancer - taxanes May 2000
TA4 Ischaemic heart disease - coronary artery stents May 2000
TA5 Liquid-based cytology for cervical screening June 2000
TA6 Taxanes for the treatment of breast cancer June 2000
TA7 The clinical and cost effectiveness of proton pump inhibitors for the treatment of dyspepsia July 2000
TA10 Guidance on the use of inhaler systems (devices) in children under the age of 5 years with chronic asthma August 2000
TA11 Implantable cardioverter defibrillators (ICDs) for the treatment of arrhythmias September 2000
TA12 Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes September 2000
TA13 Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents October 2000
TA14 The clinical and cost effectiveness of pegylated interferon alpha 2a and alpha 2b for hepatitis C October 2000
TA15 Zanamivir for the treatment of influenza in adults November 2000
TA16 Autologous cartilage transplantation for full thickness cartilage defects in knee joints December 2000
TA17 Laparoscopic surgery for colorectal cancer December 2000
TA18 Laparoscopic surgery for hernia January 2001
TA19 Alzheimer's disease (mild to moderate) - donepezil, rivastigmine and galantamine January 2001
TA20 Guidance on the Use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease January 2001
TA21 Diabetes (type 2) - pioglitazone March 2001
TA22 Orlistat for the treatment of obesity in adults March 2001
TA23 Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer) April 2001
TA24 Wound care - debriding agents April 2001
TA25 Guidance on the use of gemcitabine for the treatment of pancreatic cancer May 2001
TA26 Docetaxel, paclitaxel, gemcitabine and vinorelbine for the treatment of non-small cell lung cancer June 2001
TA27 Cox-II inhibitors for the treatment of osteoarthritis and rheumatoid arthritis July 2001
TA28 Ovarian cancer - topotecan July 2001
TA29 Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia September 2001
TA30 Taxanes for the treatment of breast cancer September 2001
TA31 The clinical effectiveness and cost effectiveness of sibutramine for obesity October 2001
TA32 Beta interferon and glatiramer acetate for the treatment of multiple sclerosis January 2002
TA33 The clinical effectiveness and cost effectiveness of irinotecan, oxaliplatin and raltitrexed for colorectal cancer March 2002
TA34 Guidance on the use of trastuzumab for the treatment of advanced breast cancer March 2002
TA35 Guidance on the use of etanercept for the treatment of juvenile idiopathic arthritis March 2002
TA36 The clinical effectiveness and cost effectiveness of etanercept and infliximab for rheumatoid arthritis and juvenile poly-articular idiopathic arthritis March 2002
TA37 The clinical effectiveness and cost effectiveness of rituximab for follicular lymphoma March 2002
TA38 Inhaler devices for routine treatment of chronic asthma in older children (aged 5–15 years) March 2002
TA39 The clinical effectiveness and cost effectiveness of bupropion (Zyban) and Nicotine Replacement Therapy for smoking cessation March 2002
TA40 The clinical effectiveness and cost effectiveness of infliximab for Crohn's Disease April 2002
TA41 The clinical effectiveness and cost effectiveness of routine anti-D prophylaxis for RhD-negative women in pregnancy May 2002
TA42 Human growth hormone for the treatment growth failure in children (review) May 2002
TA43 The clinical effectiveness and cost effectiveness of newer atypical antipsychotic drugs for schizophrenia June 2002
TA44 Guidance on the use of metal on metal hip resurfacing arthroplasty June 2002
TA45 Ovarian cancer (advanced) - paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan (review) July 2002
TA46 The clinical effectiveness and cost effectiveness of surgery for people with morbid obesity July 2002
TA47 Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes March 2010
TA48 Guidance on home compared with hospital haemodialysis for patients with end-stage renal failure September 2002
TA49 Guidance on the use of ultrasound locating devices for placing central venous catheters September 2002
TA50 Imanitib for chronic myeloid leukaemia October 2002
TA51 Computerised cognitive behaviour therapy (CCBT) for the treatment of depression and anxiety October 2002
TA52 Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction October 2002
TA53 Guidance on the use of long-acting insulin analogues for the treatment of diabetes – insulin glargine May 2008
TA54 Guidance on the use of vinorelbine for the treatment of advanced breast cancer December 2002
TA55 Guidance on the use of paclitaxel in the treatment of ovarian cancer May 2005
TA56 The clinical effectiveness and cost effectiveness of tension-free vaginal tape for stress incontinence February 2003
TA57 The clinical effectiveness and cost effectiveness of insulin pump therapy February 2003
TA58 Flu treatment - zanamivir (review), amantadine and oseltamivir February 2003
TA59 Guidance on the use of electroconvulsive therapy October 2009
TA60 Guidance on the use of patient-education models for diabetes May 2008
TA61 Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer May 2003
TA62 Guidance on the use of capecitabine for the treatment of locally advanced or metastatic breast cancer May 2003
TA63 Glitazones in the treatment of type 2 diabetes (Review of TA9 and TA21) August 2003
TA64 Human growth hormone (somatropin) in adults with growth hormone deficiency August 2003
TA65 Rituximab for aggressive non-Hodgkin's lymphoma September 2003
TA66 The clinical effectiveness and cost effectiveness of new drugs for bipolar disorder September 2003
TA67 The clinical effectiveness and cost effectiveness of amantadine and oseltamivir for the prophylaxis of influenza September 2003
TA68 Guidance on the use of photodynamic therapy for age-related macular degeneration September 2003
TA69 Guidance on the use of liquid-based cytology for cervical screening October 2003
TA70 Guidance on the use of imatinib for chronic myeloid leukaemia January 2012
TA71 Guidance on the use of coronary artery stents July 2008
TA72 The clinical effectiveness and cost effectiveness of anakinra for rheumatoid arthritis November 2003
TA73 Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction July 2011
TA74 Pre-hospital initiation of fluid replacement therapy in trauma January 2004
TA75 Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C November 2013
TA76 Newer drugs for epilepsy in adults March 2004
TA77 Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia April 2004
TA78 Fluid-filled thermal balloon and microwave endometrial ablation techniques for heavy menstrual bleeding April 2004
TA79 Newer drugs for epilepsy in children April 2004
TA80 Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome March 2010
TA81 Frequency of application of topical corticosteroids for atopic eczema August 2004
TA82 Tacrolimus and pimecrolimus for atopic eczema August 2004
TA83 Laparoscopic surgery for inguinal hernia repair September 2004
TA84 Drotrecogin alfa (activated) for severe sepsis September 2004
TA85 Immunosuppressive therapy for renal transplantation in adults September 2004
TA86 Imatinib for the treatment of unresectable and/or metastatic gastro-intestinal stromal tumours November 2010
TA87 The clinical effectiveness and cost effectiveness of technologies for the secondary prevention of osteoporotic fractures in postmenopausal women January 2005
TA88 Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome and/or atrioventricular block February 2005
TA89 The use of autologous chondrocyte implantation for the treatment of cartilage defects in the knee joints May 2005
TA90 Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events May 2005
TA91 Paclitaxel, pegylated liposomal doxorubicin hydrochloride and topotecan for second-line or subsequent treatment of advanced ovarian cancer May 2005
TA92 HealOzone for the treatment of tooth decay (occlusal pit and fissure caries and root caries) July 2005
TA93 Colorectal cancer (advanced) - irinotecan, oxaliplatin and raltitrexed (replaced by CG131) (TA93) August 2005
TA94 Statins for the prevention of cardiovascular events January 2006
TA95 Implantable cardioverter defibrillators for arrhythmias January 2006
TA96 Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B February 2006
TA97 Computerised cognitive behaviour therapy for depression and anxiety May 2013
TA98 Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents March 2006
TA99 Immunosuppressive therapy for renal transplantation in children and adolescents April 2006
TA100 Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes' C) colon cancer April 2006
TA101 Docetaxel for the treatment of hormone-refractory metastatic prostate cancer June 2006
TA102 Parent-training/education programmes in the management of children with conduct disorders July 2006
TA103 Etanercept and efalizumab for the treatment of adults with psoriasis July 2006
TA104 Etanercept and infliximab for the treatment of psoriatic arthritis July 2006
TA105 Laparoscopic surgery for colorectal cancer August 2006
TA106 Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C November 2013
TA107 Trastuzumab for the adjuvant treatment of early-stage HER2-positive breast cancer August 2006
TA108 Paclitaxel for the adjuvant treatment of early node-positive breast cancer September 2006
TA109 Docetaxel for the adjuvant treatment of early node-positive breast cancer September 2006
TA110 Rituximab for the treatment of follicular lymphoma September 2006
TA111 Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease November 2006
TA112 Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer November 2006
TA113 Inhaled insulin for the treatment of type 1 and type 2 diabetes December 2006
TA114 Methadone and buprenorphine for the management of opioid dependence January 2007
TA115 Naltrexone for the management of opioid dependence January 2007
TA116 Gemcitabine for the treatment of metastatic breast cancer January 2007
TA117 Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy January 2007
TA118 Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer January 2012
TA119 Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia February 2007
TA120 Cardiac resynchronisation therapy for the treatment of heart failure May 2007
TA121 Carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma June 2007
TA122 Alteplase for the treatment of acute ischaemic stroke September 2012
TA123 Varenicline for smoking cessation July 2007
TA124 Pemetrexed for the treatment of non-small-cell lung cancer August 2007
TA125 Adalimumab for the treatment of psoriatic arthritis August 2007
TA126 Rituximab for the treatment of rheumatoid arthritis August 2007
TA127 Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis August 2007
TA128 Stapled haemorrhoidopexy for the treatment of haemorrhoids September 2007
TA129 Bortezomib monotherapy for relapsed multiple myeloma October 2007
TA130 Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis October 2007
TA131 Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years November 2007
TA132 Ezetimibe for the treatment of primary (heterozygous-familial and non-familial) hypercholesterolaemia November 2007
TA133 Omalizumab for severe persistent allergic asthma November 2007
TA134 Infliximab for the treatment of adults with psoriasis January 2008
TA135 Pemetrexed for the treatment of malignant pleural mesothelioma January 2008
TA136 Structural neuroimaging in first-episode psychosis February 2008
TA137 Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma: Review of technology appraisal guidance 37 February 2008
TA138 Inhaled corticosteroids for the treatment of chronic asthma in adults and in children aged 12 years and over March 2008
TA139 Continuous positive airway pressure for the treatment of obstructive sleep apnoea/hypopnoea syndrome March 2008
TA140 Infliximab for subacute manifestations of ulcerative colitis April 2008
TA141 Abatacept for the treatment of rheumatoid arthritis April 2008
TA142 Epoetin alfa, epoetin beta and darbepoetin alfa for cancer treatment-induced anaemia May 2008
TA143 Adalimumab, etanercept and infliximab for ankylosing spondylitis May 2008
TA144 Rimonabant for the treatment of overweight and obese adults June 2008
TA145 Cetuximab for the treatment of locally advanced squamous cell cancer of the head and neck June 2008
TA146 Adalimumab for the treatment of adults with psoriasis June 2008
TA147 Bevacizumab for the first-line treatment of metastatic breast cancer June 2008
TA148 Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal) June 2008
TA149 Carmustine implants for the treatment of recurrent glioblastoma multiforme (terminated appraisal) June 2008
TA150 Cetuximab for the treatment of metastatic colorectal cancer following failure of oxaliplatin-containing chemotherapy January 2012
TA151 Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus July 2008
TA152 Drug-eluting stents for the treatment of coronary artery disease July 2008
TA153 Entecavir for the treatment of chronic hepatitis B August 2008
TA154 Telbivudine for the treatment of chronic hepatitis B August 2008
TA155 Ranibizumab and pegaptanib for the treatment of age-related macular degeneration May 2012
TA156 Routine antenatal anti-D prophylaxis for women who are rhesus D negative August 2008
TA157 Dabigatran etexilate for the prevention of venous thromboembolism after hip or knee replacement surgery in adults September 2008
TA158 Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza September 2008
TA159 Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin October 2008
TA160 Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women (amended) January 2011
TA161 Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women (amended) January 2011
TA162 Erlotinib for the treatment of non-small-cell lung cancer December 2012
TA163 Infliximab for acute exacerbations of ulcerative colitis December 2008
TA164 Febuxostat for the management of hyperuricaemia in people with gout December 2008
TA165 Machine perfusion systems and cold static storage of kidneys from deceased donors January 2009
TA166 Cochlear implants for children and adults with severe to profound deafness January 2009
TA167 Endovascular stent–grafts for the treatment of abdominal aortic aneurysms February 2009
TA168 Amantadine, oseltamivir and zanamivir for the treatment of influenza February 2009
TA169 Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinoma March 2009
TA170 Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults April 2009
TA171 Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy April 2014
TA172 Cetuximab for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck June 2009
TA173 Tenofovir disoproxil for the treatment of chronic hepatitis B July 2009
TA174 Rituximab for the first-line treatment of chronic lymphocytic leukaemia July 2009
TA175 Gefitinib for the second-line treatment of locally advanced or metastatic non-small-cell lung cancer (terminated appraisal) July 2009
TA176 Cetuximab for the first-line treatment of metastatic colorectal cancer August 2009
TA177 Alitretinoin for the treatment of severe chronic hand eczema August 2009
TA178 Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma August 2009
TA179 Sunitinib for the treatment of gastrointestinal stromal tumours September 2009
TA180 Ustekinumab for the treatment of adults with moderate to severe psoriasis September 2009
TA181 Pemetrexed for the first-line treatment of non-small-cell lung cancer September 2009
TA182 Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention October 2009
TA183 Topotecan for the treatment of recurrent and stage IVB cervical cancer October 2009
TA184 Topotecan for the treatment of relapsed small-cell lung cancer November 2009
TA185 Trabectedin for the treatment of advanced soft tissue sarcoma February 2010
TA186 Certolizumab pegol for the treatment of rheumatoid arthritis February 2010
TA187 Infliximab (review) and adalimumab for the treatment of Crohn's disease May 2010
TA188 Human growth hormone (somatropin) for the treatment of growth failure in children May 2010
TA189 Sorafenib for the treatment of advanced hepatocellular carcinoma May 2010
TA190 Pemetrexed for the maintenance treatment of non-small-cell lung cancer June 2010
TA191 Capecitabine for the treatment of advanced gastric cancer July 2010
TA192 Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer July 2010
TA193 Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia July 2010
TA194 Denosumab for the treatment of therapy-induced bone loss in non-metastatic prostate cancer (terminated appraisal) July 2010
TA195 Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor August 2010
TA196 Imatinib for the adjuvant treatment of gastrointestinal stromal tumours August 2010
TA197 Dronedarone for the treatment of non-permanent atrial fibrillation December 2012
TA198 Tocilizumab for the treatment of rheumatoid arthritis August 2010
TA199 Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis August 2010
TA200 Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C September 2010
TA201 Omalizumab for the treatment of severe persistent allergic asthma in children aged 6–11 October 2010
TA202 Ofatumumab for the treatment of chronic lymphocytic leukaemia refractory to fludarabine and alemtuzumab October 2010
TA203 Liraglutide for the treatment of type 2 diabetes mellitus October 2010
TA204 Denosumab for the prevention of osteoporotic fractures in postmenopausal women October 2010
TA205 Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura October 2010
TA206 Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal) October 2010
TA207 Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal) October 2010
TA208 Trastuzumab for the treatment of HER2-positive metastatic gastric cancer November 2010
TA209 Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours November 2010
TA210 Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events December 2010
TA211 Prucalopride for the treatment of chronic constipation in women December 2010
TA212 Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer December 2010
TA213 Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years January 2011
TA214 Bevacizumab in combination with a taxane for the first-line treatment of metastatic breast cancer February 2011
TA215 Pazopanib for the first-line treatment of advanced renal cell carcinoma August 2013
TA216 Bendamustine for the first-line treatment of chronic lymphocytic leukaemia February 2011
TA217 Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease March 2011
TA218 Azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia and acute myeloid leukaemia March 2011
TA219 Everolimus for the second-line treatment of advanced renal cell carcinoma April 2011
TA220 Golimumab for the treatment of psoriatic arthritis April 2011
TA221 Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura May 2014
TA222 Trabectedin for the treatment of relapsed ovarian cancer April 2011
TA223 Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease May 2011
TA224 Golimumab for the treatment of methotrexate-naive rheumatoid arthritis (terminated appraisal) June 2011
TA225 Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying anti-rheumatic drugs June 2011
TA226 Rituximab for the first-line maintenance treatment of follicular non-Hodgkin's lymphoma June 2011
TA227 Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer June 2011
TA228 Bortezomib and thalidomide for the first‑line treatment of multiple myeloma July 2011
TA229 Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion July 2011
TA230 Bivalirudin for the treatment of ST-segment-elevation myocardial infarction July 2011
TA231 Agomelatine for the treatment of major depressive episodes (terminated appraisal) July 2011
TA232 Retigabine for the adjunctive treatment of partial onset seizures in epilepsy July 2011
TA233 Golimumab for the treatment of ankylosing spondylitis August 2011
TA234 Abatacept for the treatment of rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs August 2011
TA235 Mifamurtide for the treatment of osteosarcoma October 2011
TA236 Ticagrelor for the treatment of acute coronary syndromes October 2011
TA237 Ranibizumab for the treatment of diabetic macular oedema November 2011
TA238 Tocilizumab for the treatment of systemic juvenile idiopathic arthritis December 2011
TA239 Fulvestrant for the treatment of locally advanced or metastatic breast cancer December 2011
TA240 Panitumumab in combination with chemotherapy for the treatment of metastatic colorectal cancer (terminated appraisal) December 2011
TA241 Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia (CML) (part review of NICE technology appraisal guidance 70), and dasatinib and nilotinib for people with CML for whom treatment with imatinib has failed because of intolerance January 2012
TA242 Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapy January 2012
TA243 Rituximab for the first-line treatment of stage III-IV follicular lymphoma January 2012
TA244 Roflumilast for the management of severe chronic obstructive pulmonary disease January 2012
TA245 Apixaban for the prevention of venous thromboembolism after total hip or knee replacement in adults January 2012
TA246 Pharmalgen for the treatment of bee and wasp venom allergy February 2012
TA247 Tocilizumab for the treatment of rheumatoid arthritis (rapid review of technology appraisal guidance 198) February 2012
TA248 Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes February 2012
TA249 Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation March 2012
TA250 Eribulin for the treatment of locally advanced or metastatic breast cancer April 2012
TA251 Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia (part review of technology appraisal guidance 70) April 2012
TA252 Telaprevir for the treatment of genotype 1 chronic hepatitis C April 2012
TA253 Boceprevir for the treatment of genotype 1 chronic hepatitis C April 2012
TA254 Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis April 2012
TA255 Cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen May 2012
TA256 Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation May 2012
TA257 Lapatinib or trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2 June 2012
TA258 Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancer June 2012
TA259 Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimen June 2012
TA260 Botulinum toxin type A for the prevention of headaches in adults with chronic migraine June 2012
TA261 Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism July 2012
TA262 Adalimumab for the treatment of moderate to severe ulcerative colitis (terminated appraisal) July 2012
TA263 Bevacizumab in combination with capecitabine for the first-line treatment of metastatic breast cancer August 2012
TA264 Alteplase for treating acute ischaemic stroke (review of technology appraisal guidance 122) September 2012
TA265 Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours October 2012
TA266 Mannitol dry powder for inhalation for treating cystic fibrosis November 2012
TA267 Ivabradine for treating chronic heart failure November 2012
TA268 Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma December 2012
TA269 Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma December 2012
TA270 Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal) December 2012
TA271 Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema after an inadequate response to prior therapy January 2013
TA272 Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract January 2013
TA273 Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal) January 2013
TA274 Ranibizumab for treating diabetic macular oedema (rapid review of technology appraisal guidance 237) April 2013
TA275 Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation February 2013
TA276 Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis May 2013
TA277 Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) March 2013
TA278 Omalizumab for treating severe persistent allergic asthma (review of technology appraisal guidance 133 and 201) April 2013
TA279 Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures April 2013
TA280 Abatacept for treating rheumatoid arthritis after the failure of conventional disease-modifying anti-rheumatic drugs (rapid review of technology appraisal guidance 234) April 2013
TA281 Canakinumab for treating gouty arthritis attacks and reducing the frequency of subsequent attacks (terminated appraisal) April 2013
TA282 Pirfenidone for treating idiopathic pulmonary fibrosis April 2013
TA283 Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion May 2013
TA284 Bevacizumab in combination with paclitaxel and carboplatin for first-line treatment of advanced ovarian cancer May 2013
TA285 Bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer May 2013
TA286 Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal) May 2013
TA287 Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism June 2013
TA288 Dapagliflozin in combination therapy for treating type 2 diabetes June 2013
TA289 Ruxolitinib for disease-related splenomegaly or symptoms in adults with myelofibrosis June 2013
TA290 Mirabegron for treating symptoms of overactive bladder June 2013
TA291 Pegloticase for treating severe debilitating chronic tophaceous gout June 2013
TA292 Aripiprazole for treating moderate to severe manic episodes in adolescents with bipolar I disorder July 2013
TA293 Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura (review of technology appraisal 205) July 2013
TA294 Aflibercept solution for injection for treating wet age‑related macular degeneration July 2013
TA295 Everolimus in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy August 2013
TA296 Crizotinib for previously treated non-small-cell lung cancer associated with an anaplastic lymphoma kinase fusion gene September 2013
TA297 Ocriplasmin for treating vitreomacular traction October 2013
TA298 Ranibizumab for treating choroidal neovascularisation associated with pathological myopia November 2013
TA299 Bosutinib for previously treated chronic myeloid leukaemia November 2013
TA300 Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people November 2013
TA301 Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy (rapid review of technology appraisal guidance 271) November 2013
TA302 Canakinumab for treating systemic juvenile idiopathic arthritis (terminated appraisal) November 2013
TA303 Teriflunomide for treating relapsing–remitting multiple sclerosis June 2014
TA304 Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44) February 2014
TA305 Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion February 2014
TA306 Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphoma April 2014
TA307 Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy March 2014
TA308 Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis March 2014
TA309 Pemetrexed maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small-cell lung cancer April 2014
TA310 Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancer April 2014
TA311 Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation April 2014
TA312 Alemtuzumab for treating relapsing‑remitting multiple sclerosis May 2014
TA313 Ustekinumab for treating active psoriatic arthritis May 2014
TA314 Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (review of TA95 and TA120) June 2014
TA315 Canagliflozin in combination therapy for treating type 2 diabetes June 2014
TA316 Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen July 2014
TA317 Prasugrel with percutaneous coronary intervention for treating acute coronary syndromes (review of technology appraisal guidance 182) July 2014
TA318 Lubiprostone for treating chronic idiopathic constipation July 2014
TA319 Ipilimumab for previously untreated advanced (unresectable or metastatic) melanoma July 2014
TA1000 TA test table February 2014

Writing guides

Ref Title Date issued
WG1 NICE style guide July 2014
WG2 Writing for NICE: a guide to help you write more effectively February 2014
WG3 NICE templates and formatting guide April 2014